https://curecurrent.com/trials/the-treatment-situation-of-chinese-county-population-with-breast-cancer-33001https://curecurrent.com/trials/cyclin-dependant-kinase-4-6-cdk4-6-inhibitors-as-a-second-line-treatment-in-metastatic-breast-cancer-patients-33002https://curecurrent.com/trials/hyperventilation-and-oxygenation-to-prolong-breath-hold-in-breast-cancer-irradiation-treatment-33003https://curecurrent.com/trials/pre-or-postoperative-accelerated-radiotherapy-33004https://curecurrent.com/trials/selective-image-guided-resection-of-pathologically-documented-axillary-lymph-node-metastases-33005https://curecurrent.com/trials/intra-operative-electron-boost-and-hypofractionated-whole-breast-irradiation-during-breast-conserving-treatment-bct-33006https://curecurrent.com/trials/safety-of-ofs-combined-with-ai-endocrine-therapy-in-chinese-premenopausal-breast-cancer-patients-33007https://curecurrent.com/trials/the-effect-of-art-therapy-on-pain-emesis-anxiety-and-quality-of-life-breast-cancer-33008https://curecurrent.com/trials/the-safety-management-of-cardiac-toxicity-in-breast-cancer-patients-under-multidiscipline-therapy-33009https://curecurrent.com/trials/vacuum-assisted-evacuation-vae-of-symptomatic-and-or-voluminous-breast-haematomas-following-surgeries-and-percutaneous-p-33010https://curecurrent.com/trials/effect-of-different-bandage-interface-pressures-on-breast-cancer-related-lymphedema-33011https://curecurrent.com/trials/quality-of-life-and-psychological-vulnerability-in-patients-with-rh-metastatic-breast-cancer-33012https://curecurrent.com/trials/follow-up-of-early-breast-cancer-by-dynamic-evaluation-of-cea-and-ca-15-3-followed-by-18fdg-pet-33013https://curecurrent.com/trials/efficacy-and-safety-of-ultra-hypofractionated-radiotherapy-in-women-with-breast-cancer-receiving-regional-nodal-radiatio-33014https://curecurrent.com/trials/neoadjuvant-carboplatin-in-triple-negative-breast-cancer-33015https://curecurrent.com/trials/post-treatment-surveillance-in-breast-cancer-bringing-cer-to-the-alliance-33016https://curecurrent.com/trials/quality-of-life-and-sexuality-of-patients-over-65-years-undergoing-adjuvant-treatment-for-breast-cancer-33017https://curecurrent.com/trials/laboratory-treated-t-cells-after-second-line-chemotherapy-in-treating-patients-with-her2-neu-negative-metastatic-breast-33018https://curecurrent.com/trials/feasibility-in-identification-of-breast-cancer-candidates-for-elimination-of-axillary-surgery-33019https://curecurrent.com/trials/study-evaluating-gz17-6-02-in-patients-with-advanced-solid-tumors-or-in-combination-with-capecitabine-in-metastatic-horm-33020https://curecurrent.com/trials/modifications-of-immune-microenvironment-induced-by-neoadjuvant-chemotherapy-in-triple-negative-bc-33021https://curecurrent.com/trials/effect-of-montmorillonite-power-or-loperamide-on-the-pharmacokinetics-of-pyrotinib-in-healthy-subjects-33022https://curecurrent.com/trials/hydroxychloroquine-abemaciclib-and-endocrine-therapy-in-hormone-receptor-positive-hr-her-2-negative-breast-cancer-33023https://curecurrent.com/trials/clinician-communication-about-sexual-health-33024https://curecurrent.com/trials/evaluation-of-glr2007-for-advanced-solid-tumors-33025https://curecurrent.com/trials/catheter-guided-chemo-infusion-in-breast-cancer-33026https://curecurrent.com/trials/scope-chinese-women-study-33027https://curecurrent.com/trials/quantifying-systemic-immunosuppression-to-personalize-cancer-therapy-33028https://curecurrent.com/trials/prone-breast-radiotherapy-treatment-planning-observational-study-33029https://curecurrent.com/trials/fdg-pet-ct-for-simulation-and-radiation-treatment-planning-of-early-breast-cancer-33030https://curecurrent.com/trials/bats-in-patients-with-breast-cancer-and-leptomeningeal-metastases-33031https://curecurrent.com/trials/tipops-telemedicine-vs-in-person-oncology-patient-surveillance-33032https://curecurrent.com/trials/epigenetics-of-tnbc-in-overweight-and-obese-hispanic-non-hispanic-white-women-33033https://curecurrent.com/trials/trial-comparing-prone-and-supine-intensity-modulated-radiotherapy-imrt-after-breast-conserving-surgery-in-patients-with-33034https://curecurrent.com/trials/conversational-hypnosis-in-women-undergoing-imaging-for-breast-cancer-33035https://curecurrent.com/trials/to-evaluate-the-cardiac-safety-of-pegylated-liposomal-doxorubicin-concurrently-plus-trastuzumab-and-pertuzumab-in-the-ad-33036https://curecurrent.com/trials/the-effect-of-education-given-at-different-times-before-a-breast-biopsy-33037https://curecurrent.com/trials/weight-loss-and-breast-cancer-33038https://curecurrent.com/trials/avanzando-juntas-adapting-an-evidence-based-weight-loss-program-for-hispanic-breast-cancer-survivors-33039https://curecurrent.com/trials/s1202-duloxetine-hydrochloride-for-muscle-joint-pain-in-early-stage-breast-cancer-receiving-hormone-therapy-33040https://curecurrent.com/trials/breast-cancer-brca1-carriers-a-pilot-study-33041https://curecurrent.com/trials/cancer-and-anesthesia-survival-after-radical-surgery-a-comparison-between-propofol-or-sevoflurane-anesthesia-33042https://curecurrent.com/trials/evaluate-efficacy-and-safety-of-lacudy-for-improving-vaginal-environment-in-breast-cancer-patient-33043https://curecurrent.com/trials/outcomes-of-a-deep-inferior-epigastric-perforator-flap-program-33044https://curecurrent.com/trials/study-to-assess-safety-pharmacokinetics-and-efficacy-of-oral-cc-223-for-patients-with-advanced-solid-tumors-non-hodgkin-33045https://curecurrent.com/trials/intermittent-fasting-accompanying-chemotherapy-in-gynecological-cancers-33046https://curecurrent.com/trials/reliability-and-validity-of-the-6-minute-pegboard-and-ring-test-in-patients-with-breast-cancer-33047https://curecurrent.com/trials/rct-of-fixed-vs-titrated-letrozole-in-breast-cancer-patient-undergoing-ivf-33048https://curecurrent.com/trials/the-effect-of-premedication-on-postoperative-pain-and-anxiety-in-breast-cancer-surgery-33049https://curecurrent.com/trials/rtx-224-monotherapy-in-patients-with-solid-tumors-33050https://curecurrent.com/trials/a-first-in-human-clinical-evaluation-of-sn132d-in-patients-with-breast-and-pancreatic-cancer-33051https://curecurrent.com/trials/pyrotinib-in-combination-with-capecitabine-in-patients-with-trastuzumab-resistant-her2-positive-advanced-breast-cancer-33052https://curecurrent.com/trials/hypofractionated-adjuvant-radiotherapy-in-1-versus-2-weeks-in-high-risk-patients-with-breast-cancer-hypart-33053https://curecurrent.com/trials/the-detection-of-cell-in-cell-structure-cics-in-patients-with-breast-cancer-undergoing-neoadjuvant-chemotherapy-33054https://curecurrent.com/trials/effects-of-an-exercise-intervention-on-taxane-induced-peripheral-neuropathy-in-breast-cancer-survivors-33055https://curecurrent.com/trials/breast-reconstruction-with-autologous-tissue-microsurgery-or-fat-grafting-33056https://curecurrent.com/trials/a-study-of-ty-302-in-patients-with-advanced-solid-tumors-33057https://curecurrent.com/trials/s1200-acupuncture-sham-acupuncture-or-wait-list-for-joint-symptoms-related-to-aromatase-inhibitors-in-pts-w-early-stage-33058https://curecurrent.com/trials/study-to-evaluate-relacorilant-cort125134-in-combination-with-nab-paclitaxel-in-participants-with-solid-tumors-33059https://curecurrent.com/trials/mind-body-medicine-day-care-clinic-in-breast-cancer-patients-undergoing-endocrine-therapy-33060https://curecurrent.com/trials/radiotherapy-in-combo-with-chemo-and-immunotherapy-in-patients-with-pd-l1-positive-metastatic-tnbc-33061https://curecurrent.com/trials/propranolol-hydrochloride-in-treating-patients-with-locally-recurrent-or-metastatic-solid-tumors-that-cannot-be-removed-33062https://curecurrent.com/trials/evaluation-of-breast-ct-33063https://curecurrent.com/trials/prevention-of-radiodermatitis-in-breast-and-head-and-neck-cancer-patients-in-cyprus-33064https://curecurrent.com/trials/neoadjuvant-effect-of-albumin-binding-paclitaxel-compared-with-common-paclitaxel-in-breast-cancer-an-observational-singl-33065https://curecurrent.com/trials/evaluating-the-use-of-magnetic-resonance-imaging-and-contrast-enhanced-mammography-after-magtrace-use-33066https://curecurrent.com/trials/a-study-of-mrg002-in-treatment-of-advanced-her-2-positive-breast-cancer-patients-33067https://curecurrent.com/trials/effectiveness-of-screening-and-brief-interventions-for-alcohol-and-tobacco-during-breast-cancer-treatment-onkodetox-33068https://curecurrent.com/trials/trial-to-compare-the-efficacy-and-safety-of-mw05-and-peg-rhg-csf-33069https://curecurrent.com/trials/phase-2-study-of-standard-chemotherapy-with-trastuzumab-plus-or-minus-pertuzumab-for-pre-treated-metastatic-breast-cance-33070https://curecurrent.com/trials/a-study-of-tremelimumab-and-iv-durvalumab-plus-poly-iclc-in-subjects-with-biopsy-accessible-cancers-33071https://curecurrent.com/trials/a-study-of-multiple-immune-and-disease-treatment-combinations-in-participants-with-er-her2-breast-cancer-that-has-spread-33072https://curecurrent.com/trials/neoadjuvant-study-of-pyrotinib-and-trastuzumab-plus-docetaxel-and-carboplatin-in-her2-positive-breast-cancer-patients-33073https://curecurrent.com/trials/cardiac-function-evaluation-in-breast-cancer-patients-33074https://curecurrent.com/trials/a-study-of-xmab-20717-in-subjects-with-selected-advanced-solid-tumors-33075https://curecurrent.com/trials/niraparib-in-combination-with-pembrolizumab-in-patients-with-triple-negative-breast-cancer-or-ovarian-cancer-33076https://curecurrent.com/trials/miracle-mouthwash-plus-hydrocortisone-vs-prednisolone-mouth-rinse-for-mouth-sores-caused-by-everolimus-33077https://curecurrent.com/trials/68ga-ga-aby-025-pet-for-quantification-of-her2-status-in-solid-tumors-33078https://curecurrent.com/trials/effect-of-patient-education-on-reported-bone-pain-in-breast-cancer-patients-receiving-chemotherapy-and-pegfilgrastim-33079https://curecurrent.com/trials/efficacity-of-deep-inspiration-breath-hold-and-intensity-modulated-radiotherapy-in-preventing-perfusion-defect-for-left-33080https://curecurrent.com/trials/artificial-intelligence-analysis-of-fluorescence-image-to-intraoperatively-detect-metastatic-sentinel-lymph-node-33081https://curecurrent.com/trials/safir-pi3k-a-phase-ii-randomized-maintenance-trial-comparing-alpelisib-and-fulvestrant-versus-chemotherapy-in-pik3ca-mut-33082https://curecurrent.com/trials/first-in-human-phase-1-study-of-ag01-anti-progranulin-gp88-antibody-in-advanced-solid-tumor-malignancies-33083https://curecurrent.com/trials/a-study-of-debio-1347-plus-fulvestrant-in-patients-with-metastatic-breast-cancer-33084https://curecurrent.com/trials/nonmyeloablative-allogeneic-transplant-33085https://curecurrent.com/trials/gm1-in-the-treatment-of-neurotoxicity-induced-by-albumin-bound-paclitaxel-33086https://curecurrent.com/trials/safety-and-efficacy-of-eribullin-or-eribulin-combined-with-anlotinib-in-metastatic-breast-cancer-33087https://curecurrent.com/trials/impact-of-a-breast-cancer-survivorship-interprofessional-community-care-model-33088https://curecurrent.com/trials/a-study-of-pyrotinib-in-combination-with-trastuzumab-and-docetaxel-in-patients-with-her2-metastatic-breast-cancer-33089https://curecurrent.com/trials/su11248-as-consolidation-after-response-to-taxanes-in-metastatic-breast-cancer-33090https://curecurrent.com/trials/a-study-evaluating-safety-pharmacokinetics-and-therapeutic-activity-of-ro6874281-as-a-single-agent-part-a-or-in-combinat-33091https://curecurrent.com/trials/a-study-of-local-therapy-for-the-treatment-of-brain-metastases-from-her2-positive-breast-cancer-33092https://curecurrent.com/trials/type-i-polarized-autologous-dendritic-cell-vaccine-with-tumor-blood-vessel-antigen-derived-peptides-in-metastatic-breast-33093https://curecurrent.com/trials/aspects-of-breast-conserving-surgery-33094https://curecurrent.com/trials/monocentric-perspective-study-use-of-liquid-biopsy-with-diagnostic-imaging-33095https://curecurrent.com/trials/99mtc-mirc213-spect-ct-for-the-detection-of-her2-positive-breast-cancer-33096https://curecurrent.com/trials/study-on-androgen-receptor-and-triple-negative-breast-cancer-33097https://curecurrent.com/trials/small-group-virtual-program-for-improving-symptoms-and-distress-related-to-hormonal-therapy-for-breast-cancer-survivors-33098https://curecurrent.com/trials/68ga-pet-ct-imaging-in-breast-cancer-patients-33099https://curecurrent.com/trials/a-study-to-evaluate-inetetamab-pyrotinib-chemotherapy-in-previously-untreated-her2-positive-metastatic-breast-cancer-33100https://curecurrent.com/trials/stars-breast-trial-study-of-anastrozole-and-radiotherapy-sequencing-33101https://curecurrent.com/trials/relationship-between-serum-interleukin-20-level-and-paclitaxel-associated-neuropathy-33102https://curecurrent.com/trials/genetic-testing-or-clinical-assessment-in-determining-the-need-for-chemotherapy-in-women-with-breast-cancer-that-involve-33103https://curecurrent.com/trials/elderly-metastatic-breast-cancer-pertuzumab-herceptin-vs-pertuzumab-herceptin-metronomic-chemotherapy-followed-by-t-dm1-33104https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-cesm-breast-cancer-screening-33105https://curecurrent.com/trials/bisphenol-and-phthalate-exposures-in-triple-negative-breast-cancer-33106https://curecurrent.com/trials/study-of-acupuncture-in-the-treatment-of-hot-flashes-in-patients-with-hormone-receptor-positive-breast-cancer-33107https://curecurrent.com/trials/artificial-intelligence-analysis-for-magnetic-resonance-imaging-in-screening-breast-cancer-in-high-risk-women-33108https://curecurrent.com/trials/the-possible-efficacy-and-safety-of-lansoprazole-co-administration-with-neoadjuvant-chemotherapy-in-women-with-breast-ca-33109https://curecurrent.com/trials/a-phase-iii-trial-of-niraparib-versus-physician-s-choice-in-her2-negative-germline-brca-mutation-positive-breast-cancer-33110https://curecurrent.com/trials/sgt-53-carboplatin-and-pembrolizumab-for-the-treatment-of-metastatic-triple-negative-inflammatory-breast-cancer-33111https://curecurrent.com/trials/partial-breast-irradiation-pbi-for-selected-patients-with-early-invasive-or-non-invasive-breast-cancer-33112https://curecurrent.com/trials/characterizing-breast-cancer-with-18f-fes-pet-ct-33113https://curecurrent.com/trials/study-to-evaluate-effectiveness-of-investigational-device-in-the-assistance-of-detection-and-diagnosis-of-breast-cancer-33114https://curecurrent.com/trials/diagnostic-performance-and-safety-of-18f-naf-pet-ct-in-bone-metastases-compared-with-99mtc-mdp-bs-spect-33115https://curecurrent.com/trials/platinum-and-polyadenosine-5-diphosphoribose-polymerisation-inhibitor-for-neoadjuvant-treatment-of-triple-negative-breas-33116https://curecurrent.com/trials/a-study-to-measure-the-expression-of-the-her2-her3-dimer-in-tumour-and-blood-exosomes-samples-from-patients-with-her2-po-33117https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-impact-of-dexmedetomidine-on-breast-cancer-recurrence-after-surgery-33118https://curecurrent.com/trials/technology-supported-physical-activity-intervention-for-metastatic-breast-cancer-survivors-fit2thrivemb-33119https://curecurrent.com/trials/development-of-a-genetic-counseling-patient-preference-intervention-for-women-at-elevated-risk-for-breast-cancer-33120https://curecurrent.com/trials/a-research-study-for-latina-women-undergoing-breast-cancer-treatment-33121https://curecurrent.com/trials/atezolizumab-with-nab-paclitaxel-for-patients-with-triple-negative-stage-iv-breast-cancer-33122https://curecurrent.com/trials/multidisciplinary-approach-to-fatigue-33123https://curecurrent.com/trials/ribociclib-in-combination-with-non-steroidal-aromatase-inhibitors-in-patients-with-advanced-breast-cancer-33124https://curecurrent.com/trials/glucagon-receptor-inhibition-to-enable-breast-cancer-patients-to-benefit-from-pi3k-inhibitor-therapy-remd-477-33125https://curecurrent.com/trials/an-individualised-treatment-vs-a-minimal-program-in-women-with-late-term-shoulder-impairments-after-breast-cancer-33126https://curecurrent.com/trials/safety-study-of-amg-386-to-treat-her2-positive-locally-recurrent-or-metastatic-breast-cancer-33127https://curecurrent.com/trials/evaluation-of-the-feasibility-of-developing-personalized-breast-cancer-radiotherapy-assistive-device-with-3d-printing-33128https://curecurrent.com/trials/investigation-of-the-effect-of-education-on-symptom-management-on-symptom-management-in-patients-with-breast-cancer-33129https://curecurrent.com/trials/glucosamine-and-chondroitin-for-aromatase-inhibitor-induced-joint-symptoms-in-women-with-breast-cancer-33130https://curecurrent.com/trials/a-study-comparing-denosumab-vs-zoledronic-acid-for-the-treatment-of-bone-metastases-in-breast-cancer-subjects-33131https://curecurrent.com/trials/effect-of-acupuncture-vs-chinese-medicine-vs-combined-therapy-on-aromatase-inhibitor-related-arthralgia-among-women-with-33132https://curecurrent.com/trials/comparison-of-the-cosmetic-outcome-of-hypofractionated-versus-normofractionated-imrt-in-treatment-of-breast-cancer-33133https://curecurrent.com/trials/study-of-denosumab-vs-zoledronic-acid-to-treat-bone-metastases-in-subjects-with-advanced-cancer-or-multiple-myeloma-33134https://curecurrent.com/trials/factor-influencing-breast-surgery-type-decision-making-33135https://curecurrent.com/trials/neoadjuvant-treatment-of-triple-negative-breast-cancer-patients-with-docetaxel-and-carboplatin-to-assess-anti-tumor-acti-33136https://curecurrent.com/trials/fruit-and-vegetable-intervention-in-lactating-women-to-reduce-breast-cancer-risk-33137https://curecurrent.com/trials/the-effect-of-digital-breast-tomosynthesis-in-breast-cancer-long-term-survival-a-single-institution-study-33138https://curecurrent.com/trials/tucidinostat-and-metronomic-capecitabine-for-metastatic-triple-negative-breast-cancer-a-multicenter-open-label-randomize-33139https://curecurrent.com/trials/aerobic-training-and-diet-on-the-immune-system-in-postmastectomy-patients-receiving-chemotherapy-33140https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-efficacy-of-breast-implant-33141https://curecurrent.com/trials/onalespib-and-paclitaxel-in-treating-patients-with-advanced-triple-negative-breast-cancer-33142https://curecurrent.com/trials/tucidinostat-combined-with-metronomic-capecitabine-and-endocrine-therapy-for-advanced-hr-positive-her2-negative-breast-c-33143https://curecurrent.com/trials/fish-oil-and-epo-in-breast-cancer-33144https://curecurrent.com/trials/a-new-mindfulness-intervention-called-mindfulness-based-swinging-technique-mbst-for-women-with-breast-cancer-33145https://curecurrent.com/trials/ds-8201a-in-patients-with-cancer-that-tests-positive-for-human-epidermal-growth-factor-receptor-2-her2-protein-33146https://curecurrent.com/trials/the-reach-study-a-novel-values-based-intervention-to-increase-endocrine-therapy-adherence-among-breast-cancer-survivors-33147https://curecurrent.com/trials/an-attention-restorative-therapy-art-based-virtual-reality-intervention-to-address-cancer-related-cognitive-impairments-33148https://curecurrent.com/trials/correlation-of-preoperative-anxiety-with-early-postoperative-cognitive-dysfunction-in-breast-cancer-patients-33149https://curecurrent.com/trials/effect-of-heavy-load-resistance-training-during-chemotherapy-on-muscle-cellular-outcomes-33150https://curecurrent.com/trials/study-of-the-therapeutic-effect-of-atorvastatin-on-the-clinical-outcomes-in-her2-negative-breast-cancer-patients-33151https://curecurrent.com/trials/optimizing-psychological-treatment-for-pain-after-breast-cancer-33152https://curecurrent.com/trials/a-study-of-t3011-administered-via-intratumoral-injection-in-patients-with-advanced-solid-tumors-33153https://curecurrent.com/trials/multidisciplinary-rehabilitation-programme-for-breast-cancer-33154https://curecurrent.com/trials/sleep-coach-a-mobile-app-to-address-insomnia-symptoms-among-cancer-survivors-33155https://curecurrent.com/trials/a-study-to-assess-pv-10-chemoablation-of-cancer-of-the-liver-33156https://curecurrent.com/trials/fibrin-sealant-in-preventing-fluid-build-up-during-surgery-in-patients-undergoing-breast-reconstruction-33157https://curecurrent.com/trials/a-prospective-study-of-preoperative-tumor-bed-boost-followed-by-oncoplastic-surgery-and-adjuvant-whole-breast-radiothera-33158https://curecurrent.com/trials/diagnostic-performance-of-an-automated-breast-ultrasound-system-abus-33159https://curecurrent.com/trials/mbsr-during-ai-therapy-for-breast-cancer-33160https://curecurrent.com/trials/vinorelbine-metronomic-chemotherapy-combined-with-hypofractionated-radiotherapy-pd-1-pd-l1-sequential-gm-csf-and-il-2-fo-33161https://curecurrent.com/trials/evaluation-of-taihao-breast-ultrasound-diagnosis-software-33162https://curecurrent.com/trials/accuracy-of-fna-versus-cnb-of-abnormal-axillary-lymph-nodes-in-setting-of-invasive-breast-cancer-33163https://curecurrent.com/trials/development-of-a-horizontal-data-integration-classifier-for-noninvasive-early-diagnosis-of-breast-cancer-33164https://curecurrent.com/trials/effect-of-trastuzumab-on-disease-free-survival-in-early-stage-her2-negative-breast-cancer-patients-with-erbb2-expressing-33165https://curecurrent.com/trials/breast-tumor-oxygenation-during-exercise-33166https://curecurrent.com/trials/predicting-pathological-response-within-the-1st-week-of-chemotherapy-using-diffuse-optical-spectroscopic-imaging-33167https://curecurrent.com/trials/a-pilot-study-of-the-combination-of-entinostat-with-capecitabine-in-high-risk-breast-cancer-after-neo-adjuvant-therapy-33168https://curecurrent.com/trials/integration-of-cancer-health-activities-into-african-american-churches-33169https://curecurrent.com/trials/monitoring-and-predicting-breast-cancer-neoadjuvant-chemotherapy-response-using-diffuse-optical-spectroscopic-imaging-33170https://curecurrent.com/trials/monitoring-the-response-of-chemotherapy-on-breast-cancer-tumor-by-photon-migration-spectroscopy-33171https://curecurrent.com/trials/monitoring-and-predicting-breast-cancer-neoadjuvant-chemotherapy-response-using-dosi-33172https://curecurrent.com/trials/implementation-and-quality-assurance-of-dpyd-genotyping-in-patients-treated-with-fluoropyrimidines-33173https://curecurrent.com/trials/evaluating-tocilizumab-for-sever-covid-19-infection-in-breast-cancer-vs-non-cancer-pateints-33174https://curecurrent.com/trials/axillary-versus-primary-breast-approach-for-second-stage-breast-reconstruction-33175https://curecurrent.com/trials/non-invasive-magnetic-resonance-imaging-mri-and-magnetic-resonance-spectroscopy-techniques-mrs-for-assessing-neoadjuvant-33176https://curecurrent.com/trials/a-phase-i-dose-escalation-study-of-eribulin-plus-weekly-carboplatin-for-metastatic-breast-patients-33177https://curecurrent.com/trials/m7824-and-eribulin-mesylate-in-treating-patients-with-metastatic-triple-negative-breast-cancer-33178https://curecurrent.com/trials/the-anti-tumor-effect-of-metformin-and-atorvastatin-in-breast-cancer-33179https://curecurrent.com/trials/targeting-the-pam50-her2-enriched-phenotype-with-enzalutamide-in-hormone-receptor-positive-her2-negative-metastatic-bc-33180https://curecurrent.com/trials/neoadjuvant-nab-paclitaxel-in-triple-negative-or-her2-positive-breast-cancer-33181https://curecurrent.com/trials/prospective-evaluation-of-a-surgical-solution-for-breast-cancer-associated-lymphedema-33182https://curecurrent.com/trials/study-to-evaluate-the-sensitivity-of-the-linda-thermal-device-33183https://curecurrent.com/trials/epirubicin-versus-docetaxel-plus-cyclophosphamide-in-lymph-node-negative-er-positive-her2-negative-breast-cancer-33184https://curecurrent.com/trials/self-efficacy-coaching-for-women-with-breast-cancer-33185https://curecurrent.com/trials/a-feasibility-study-of-the-bone-bc-app-version-3-0-33186https://curecurrent.com/trials/neoadjuvant-medi4736-concomitant-with-weekly-nab-paclitaxel-and-dose-dense-ac-for-stage-i-iii-triple-negative-breast-can-33187https://curecurrent.com/trials/elacestrant-in-preoperative-setting-a-window-of-opportunity-study-33188https://curecurrent.com/trials/effect-of-prophylactic-medical-compression-therapy-on-the-reduction-of-breast-cancer-related-lymphedema-in-patients-with-33189https://curecurrent.com/trials/effect-of-lymphedema-prevention-program-based-on-theory-of-knowledge-attitude-practice-on-postoperative-breast-cancer-pa-33190https://curecurrent.com/trials/extension-study-to-provide-adjuvant-treatment-following-neoadjuvant-treatment-and-surgical-resection-in-protocol-tx05-03-33191https://curecurrent.com/trials/fear-focused-self-compassion-therapy-for-young-breast-cancer-patients-fear-of-cancer-recurrence-33192https://curecurrent.com/trials/role-of-silymarin-in-chemotherapy-toxicity-and-cognition-improvement-in-breast-cancer-patients-33193https://curecurrent.com/trials/feasibility-of-a-modular-mhealth-for-tailored-rehabilitation-of-breast-cancer-33194https://curecurrent.com/trials/targeting-egfr-erbb2-with-neratinib-in-hormone-receptor-hr-positive-her2-negative-her2-enriched-advanced-metastatic-brea-33195https://curecurrent.com/trials/virtual-trial-to-compare-two-digital-therapeutics-as-interventions-for-physical-and-mental-health-in-people-with-cancer-33196https://curecurrent.com/trials/family-history-and-breast-cancer-education-trial-33197https://curecurrent.com/trials/accelerated-hypofractionated-1-week-radiotherapy-in-breast-cancer-patients-33198https://curecurrent.com/trials/palbociclib-plus-letrozole-in-hormone-receptor-positive-residual-disease-after-neoadjuvant-chemotherapy-33199https://curecurrent.com/trials/a-phase-1-study-of-mixed-bacteria-vaccine-mbv-in-patients-with-tumors-expressing-ny-eso-1-antigen-33200https://curecurrent.com/trials/a-phase-ii-window-of-opportunity-trial-of-prmt5-inhibitor-gsk3326595-in-early-stage-breast-cancer-33201https://curecurrent.com/trials/a-study-of-pyrotinib-plus-capecitabine-in-patients-with-her2-metastatic-breast-cancer-33202https://curecurrent.com/trials/diarrhea-prevention-and-prophylaxis-with-crofelemer-in-her2-positive-breast-cancer-patients-33203https://curecurrent.com/trials/a-study-of-palbociclib-in-combination-with-bazedoxifene-in-hormone-receptor-positive-breast-cancer-33204https://curecurrent.com/trials/effect-of-physical-activity-in-patients-with-breast-cancer-33205https://curecurrent.com/trials/comparing-letrozole-given-alone-to-letrozole-given-with-avastin-in-post-menopausal-women-breast-cancer-33206https://curecurrent.com/trials/ultrasound-guided-erector-spinae-plane-block-versus-paravertebral-block-in-breast-cancer-patients-undergoing-mastectomy-33207https://curecurrent.com/trials/efficacy-of-lithium-against-chemotherapy-induced-neutropenia-in-breast-cancer-patients-33208https://curecurrent.com/trials/s1415cd-trial-assessing-csf-prescribing-effectiveness-and-risk-tracer-33209https://curecurrent.com/trials/role-of-exercise-in-breast-cancer-patient-undergoing-treatment-33210https://curecurrent.com/trials/diagnosis-value-of-sema4c-in-breast-cancer-33211https://curecurrent.com/trials/fasting-mimicking-diet-in-patients-undergoing-active-cancer-treatment-33212https://curecurrent.com/trials/monitoring-of-chronic-conditions-in-breast-cancer-33213https://curecurrent.com/trials/effects-of-meditation-on-cognitive-function-and-quality-of-life-33214https://curecurrent.com/trials/correlation-of-predictive-accuracy-of-predict-version-2-2-of-indian-women-with-operable-breast-cancer-33215https://curecurrent.com/trials/pre-surgical-study-effect-of-metformin-on-breast-cancer-proliferation-33216https://curecurrent.com/trials/4-1bb-agonist-monoclonal-antibody-pf-05082566-with-trastuzumab-emtansine-or-trastuzumab-in-treating-patients-with-advanc-33217https://curecurrent.com/trials/epidemiology-of-tnbc-in-asyut-clinical-oncology-department-33218https://curecurrent.com/trials/trastuzumab-pyrotinib-combined-with-dalpiciclib-and-endocrine-therapy-for-hr-her2-advanced-breast-cancer-33219https://curecurrent.com/trials/blue-note-therapeutics-product-bnt-103-usability-and-user-engagement-33220https://curecurrent.com/trials/ultra-hypofractionated-radiotherapy-in-breast-cancer-patients-33221https://curecurrent.com/trials/study-to-assess-the-efficacy-of-pembrolizumab-plus-radiotherapy-in-metastatic-triple-negative-breast-cancer-patients-33222https://curecurrent.com/trials/efficacy-and-safety-of-combinition-of-camrelizumab-in-second-line-neoadjuvant-chemotherapy-and-adjuvant-therapy-33223https://curecurrent.com/trials/comparison-of-two-types-of-biopsy-in-suspicious-axillary-lymph-nodes-33224https://curecurrent.com/trials/automating-breast-radiation-therapy-rt-33225https://curecurrent.com/trials/breast-density-change-predicting-response-to-adjuvant-aromatase-inhibitor-33226https://curecurrent.com/trials/the-value-of-high-resolution-ultrasound-in-the-detection-of-lymph-node-metastasis-a-proposal-of-ni-rads-33227https://curecurrent.com/trials/concurrent-paclitaxel-and-radiotherapy-after-adjuvant-doxorubicin-and-cyclophosphamide-for-stage-2-or-3-breast-cancer-33228https://curecurrent.com/trials/prospective-feasibility-study-applying-the-acosog-z0011-criteria-to-chinese-patients-33229https://curecurrent.com/trials/study-of-coq10-during-one-cycle-of-doxorubicin-treatment-for-breast-cancer-33230https://curecurrent.com/trials/a-comparison-between-biological-veritas-vs-non-biological-mesh-tigr-in-immediate-breast-reconstruction-33231https://curecurrent.com/trials/the-oncological-safety-and-cosmetic-outcome-of-areola-sparing-mastectomy-a-single-arm-prospective-cohort-study-33232https://curecurrent.com/trials/intestinal-microbiota-impact-for-prognosis-and-treatment-outcomes-in-early-luminal-breast-cancer-and-pancreatic-cancer-p-33233https://curecurrent.com/trials/phase-i-human-analytics-halo-study-33234https://curecurrent.com/trials/decision-support-following-genetic-testing-for-breast-ovarian-cancer-susceptibility-33235https://curecurrent.com/trials/radiotherapy-after-primary-chemotherapy-for-breastcancer-33236https://curecurrent.com/trials/nab-paclitaxel-dose-schedual-for-her-2-negative-advanced-breast-cancer-33237https://curecurrent.com/trials/89zrtrastuzumab-breast-imaging-with-positron-emission-tomography-33238https://curecurrent.com/trials/exploring-whether-disease-free-intervals-can-guide-endocrine-combined-targeted-therapy-for-er-her2-advanced-breast-cance-33239https://curecurrent.com/trials/cardiac-mri-biomarker-testing-gcc-1618-33240https://curecurrent.com/trials/monalisa-laser-intervention-for-post-menopausal-breast-cancer-patients-a-she-can-study-33241https://curecurrent.com/trials/develop-and-evaluate-the-effectiveness-of-a-self-care-smartphone-application-on-the-self-efficacy-and-resilience-among-n-33242https://curecurrent.com/trials/neo-adjuvant-chemotherapy-in-triple-negative-breast-cancer-33243https://curecurrent.com/trials/high-dose-chemotherapy-in-oligo-metastatic-homologous-recombination-deficient-breast-cancer-33244https://curecurrent.com/trials/safety-and-efficacy-of-trastuzumab-as-part-of-breast-cancer-treatment-regimen-33245https://curecurrent.com/trials/sensorimotor-rehabilitation-program-in-improving-quality-of-life-in-patients-with-early-stage-breast-cancer-33246https://curecurrent.com/trials/palbociclib-and-fes-pet-33247https://curecurrent.com/trials/a-phase-1-study-to-evaluate-medi4736-in-combination-with-tremelimumab-33248https://curecurrent.com/trials/simultaneous-integrated-boost-technique-in-breast-cancer-radiotherapy-33249https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-effectiveness-of-gdc-0032-when-given-alongside-tamoxifen-33250https://curecurrent.com/trials/single-arm-multi-center-clinical-study-of-pyrotinib-maleate-tablets-combined-with-albumin-bound-paclitaxel-and-trastuzum-33251https://curecurrent.com/trials/breast-cancer-liquid-biopsy-stratification-33252https://curecurrent.com/trials/the-women-in-steady-exercise-research-wiser-survivor-trial-33253https://curecurrent.com/trials/mobile-behavior-change-program-for-weight-loss-in-breast-cancer-survivors-33254https://curecurrent.com/trials/breast-and-cervical-cancer-educational-intervention-for-latinas-in-western-new-york-33255https://curecurrent.com/trials/breast-cancer-screening-for-underserved-women-comparing-outcomes-and-lowering-recall-rates-with-3d-vs-2d-mammography-33256https://curecurrent.com/trials/effects-of-interpectoral-pectoserratus-plane-block-after-breast-cancer-surgery-33257https://curecurrent.com/trials/omega-3-fatty-acid-in-treating-pain-in-patients-with-breast-or-ovarian-cancer-receiving-paclitaxel-33258https://curecurrent.com/trials/hgwd-improve-the-paclitaxel-related-neurotoxicity-in-patients-with-bc-33259https://curecurrent.com/trials/physical-activity-and-balance-changes-in-operated-patients-because-of-breast-cancer-33260https://curecurrent.com/trials/prediction-of-individual-radiosensitivity-during-radiotherapy-for-breast-cancer-patients-33261https://curecurrent.com/trials/phase-ii-clinical-study-of-t-dm1-and-pyrotinib-maleate-in-patients-with-her2-positive-metastatic-breast-cancer-who-had-p-33262https://curecurrent.com/trials/trial-of-active-immunotherapy-with-obi-833-globo-h-crm197-in-advanced-metastatic-gastric-lung-colorectal-or-breast-cance-33263https://curecurrent.com/trials/mid-point-transverse-process-to-pleura-block-for-breast-cancer-surgery-a-randomized-controlled-trial-33264https://curecurrent.com/trials/in-vitro-detection-of-tissue-abnormality-33265https://curecurrent.com/trials/rehabilitation-through-hippotherapy-for-the-management-of-women-after-primary-treatment-of-breast-cancer-33266https://curecurrent.com/trials/real-world-study-of-pyrotinib-in-neoadjuvant-therapy-for-her2-positive-breast-cancer-33267https://curecurrent.com/trials/evaluating-optimal-timing-of-endocrine-therapy-and-radiation-therapy-in-early-stage-breast-cancer-react-rett-33268https://curecurrent.com/trials/fulvestrant-versus-capecitabine-as-maintenance-therapy-after-first-line-chemotherapy-in-patients-with-hr-her2-metastatic-33269https://curecurrent.com/trials/a-single-arm-open-exploratory-clinical-study-of-pemigatinib-in-the-treatment-of-her2-negative-advanced-breast-cancer-pat-33270https://curecurrent.com/trials/pre-versus-postoperative-accelerated-partial-breast-irradiation-33271https://curecurrent.com/trials/advanced-breast-cancer-study-of-cdk4-6-inhibitor-combined-with-endocrine-therapy-endocrine-therapy-in-hr-her2-advanced-b-33272https://curecurrent.com/trials/brazilian-outcome-for-metastatic-breast-cancer-33273https://curecurrent.com/trials/nipple-sparing-mastectomy-in-combined-with-buried-flap-monitoring-33274https://curecurrent.com/trials/comparison-between-serratus-anterior-plane-block-and-erector-spinae-plane-block-for-mastectomy-33275https://curecurrent.com/trials/fluzoparib-in-combination-with-chidamide-or-camrelizumab-for-hrd-positive-her2-negative-advanced-breast-cancer-33276https://curecurrent.com/trials/project-insight-feasibility-of-a-breast-cancer-screening-decision-support-tool-33277https://curecurrent.com/trials/study-of-cb-839-in-combination-w-paclitaxel-in-participants-of-african-ancestry-and-non-african-ancestry-with-advanced-t-33278https://curecurrent.com/trials/a-pilot-tele-rehabilitation-trial-for-breast-cancer-survivors-33279https://curecurrent.com/trials/circulating-cancer-cells-macrophage-hybrid-cells-in-patients-with-breast-cancer-33280https://curecurrent.com/trials/comparison-of-analgesic-efficacy-of-ultrasound-guided-rhomboid-intercostal-block-versus-serratus-anterior-plane-block-fo-33281https://curecurrent.com/trials/study-of-pazopanib-paclitaxel-and-carboplatin-in-patients-with-advanced-solid-tumors-33282https://curecurrent.com/trials/comparison-between-pecs-block-2-vs-esp-block-in-ocnologic-breast-surgery-33283https://curecurrent.com/trials/personalized-follow-up-after-breast-cancer-surgery-via-electronic-patient-reported-outcomes-33284https://curecurrent.com/trials/a-study-exploring-the-safety-and-efficacy-of-incagn01949-in-combination-with-immune-therapies-in-advanced-or-metastatic-33285https://curecurrent.com/trials/dynamic-contrast-enhanced-mri-combined-with-ivim-dwi-for-early-prediction-of-chemosensitivity-in-liver-mbc-33286https://curecurrent.com/trials/copanlisib-letrozole-and-palbociclib-in-treating-patients-with-hormone-receptor-positive-her2-negative-stage-i-iv-breast-33287https://curecurrent.com/trials/serratus-anterior-plane-block-to-prevent-chronic-postoperative-pain-in-breast-cancer-33288https://curecurrent.com/trials/protection-of-cardiovascular-function-with-crocin-in-breast-cancer-patients-undergoing-radiotherapy-and-chemotherapy-33289https://curecurrent.com/trials/molecular-alterations-associated-with-resistance-to-endocrine-therapy-and-impacting-treatment-with-mtor-inhibitor-33290https://curecurrent.com/trials/freezing-breast-cancer-in-brazil-a-before-after-study-33291https://curecurrent.com/trials/phase-1b-trial-of-dinaciclib-with-pembrolizumab-for-advanced-breast-cancer-33292https://curecurrent.com/trials/health-promoting-lifestyle-in-a-genetic-counseling-clinic-33293https://curecurrent.com/trials/evaluation-of-the-efficacy-of-a-homeopathic-protocol-in-patients-with-non-metastatic-breast-cancer-33294https://curecurrent.com/trials/pyrotinib-combined-with-capecitabine-in-her-2-positive-advanced-breast-cancer-and-brain-metastases-post-permeate-33295https://curecurrent.com/trials/eribulin-mesylate-combined-with-lobaplatin-in-the-treatment-of-recurrent-or-metastatic-triple-negative-breast-cancer-33296https://curecurrent.com/trials/stereotactic-radiation-therapy-with-or-without-whole-brain-radiation-therapy-in-treating-patients-with-brain-metastases-33297https://curecurrent.com/trials/utidelone-plus-bevacizumab-for-advanced-breast-cancer-with-brain-metastases-33298https://curecurrent.com/trials/a-double-blind-study-of-paclitaxel-in-combination-with-reparixin-or-placebo-for-metastatic-triple-negative-breast-cancer-33299https://curecurrent.com/trials/cancer-survival-through-weight-loss-and-exercise-33300https://curecurrent.com/trials/estrogen-receptor-er-pet-ct-imaging-in-breast-cancer-33301https://curecurrent.com/trials/99mtc-hpark2-spect-ct-for-the-detection-of-her2-positive-breast-cancer-33302https://curecurrent.com/trials/pilot-study-of-a-an-app-to-improve-medication-adherence-in-breast-cancer-survivors-receiving-ais-33303https://curecurrent.com/trials/registrational-trial-to-compare-effectiveness-of-two-digital-software-medical-devices-as-adjunctive-oncology-treatment-33304https://curecurrent.com/trials/histological-modifications-of-postmenopausal-vaginal-mucosa-after-repeated-carbon-dioxide-co2-laser-treatment-33305https://curecurrent.com/trials/a-study-of-pf-05212384-in-combination-with-other-anti-tumor-agents-and-in-combination-with-cisplatin-in-patients-with-tr-33306https://curecurrent.com/trials/evaluate-the-safety-tolerability-biodistribution-and-anti-tumour-activity-of-177lu-ops201-with-companion-imaging-68ga-op-33307https://curecurrent.com/trials/the-efficiency-for-stage-ii-iii-hr-her2-early-breast-cancer-patient-with-standard-neoadjuvant-therapy-in-real-world-33308https://curecurrent.com/trials/contraception-and-cervical-and-breast-cancer-screening-in-obese-versus-non-obese-women-33309https://curecurrent.com/trials/phase-ii-multicenter-study-of-durvalumab-and-olaparib-in-platinum-treated-advanced-triple-negative-breast-cancer-dora-33310https://curecurrent.com/trials/pyrotinib-maleate-trastuzumab-shr6390-and-letrozole-in-combination-for-stage-ii-iii-tpbc-33311https://curecurrent.com/trials/arx788-in-selected-her2-mutated-or-her2-amplified-overexpressed-solid-tumors-ace-pan-tumor-02-33312https://curecurrent.com/trials/reduced-contrast-administration-in-contrast-enhanced-spectral-mammography-cesm-33313https://curecurrent.com/trials/efficacy-and-safety-of-pyrotinib-maleate-combined-with-arx788-neoadjuvant-treatment-in-breast-cancer-patients-33314https://curecurrent.com/trials/photobiomodulation-for-prevention-of-radiodermatitis-in-women-with-breast-cancer-undergoing-adjuvant-radiotherapy-33315https://curecurrent.com/trials/anti-mullerian-hormone-amh-as-marker-of-ovarian-reserve-33316https://curecurrent.com/trials/a-phase-ii-single-arm-pilot-study-of-the-chk1-2-inhibitor-ly2606368-in-brca1-2-mutation-associated-breast-or-ovarian-can-33317https://curecurrent.com/trials/role-of-adding-metformin-to-neoadjuvant-chemotherapy-in-patients-with-breast-cancer-metneo-33318https://curecurrent.com/trials/ad-her2-neu-dendritic-cell-cancer-vaccine-testing-33319https://curecurrent.com/trials/18f-flt-pet-imaging-of-the-brain-in-patients-with-metastatic-breast-cancer-to-the-brain-treated-with-whole-brain-radiati-33320https://curecurrent.com/trials/remote-electronic-assessment-of-survivors-with-feedback-communication-and-directed-referrals-33321https://curecurrent.com/trials/impact-of-breast-cancer-treatment-on-joint-health-cartilage-composition-and-bone-structure-in-the-knee-and-hand-33322https://curecurrent.com/trials/tele-rehabilitation-in-women-with-breast-cancer-during-covid-19-pandemic-33323https://curecurrent.com/trials/a-study-of-mrg002-in-the-treatment-of-patients-with-her2-low-locally-advanced-or-metastatic-breast-cancer-bc-33324https://curecurrent.com/trials/iort-boost-study-prospective-observational-study-for-intraoperative-radiotherapy-of-the-breast-as-a-boost-33325https://curecurrent.com/trials/a-prospective-single-center-cohort-study-preoperative-identification-of-sentinel-lymph-nodes-using-contrast-enhanced-ct-33326https://curecurrent.com/trials/lavage-of-the-uterine-cavity-for-the-diagnosis-of-serous-tubal-intraepithelial-carcinoma-33327https://curecurrent.com/trials/entertainment-media-to-deliver-educational-messages-about-mammography-in-saudi-arabia-33328https://curecurrent.com/trials/early-detection-of-high-grade-ovarian-cancer-using-uterine-lavage-ehud-study-and-duplex-sequencing-33329https://curecurrent.com/trials/an-exploratory-study-of-surufatinib-combined-with-chidamide-and-fulvestrant-in-hr-positive-unresectable-metastatic-breas-33330https://curecurrent.com/trials/effect-of-hemp-cbd-on-patients-with-cipn-33331https://curecurrent.com/trials/dcb-docetaxel-carboplatin-versus-ec-d-epirubicin-cyclophosphamide-followed-by-docetaxe-as-neoadjuvant-chemotherapy-for-t-33332https://curecurrent.com/trials/shr9549-in-er-positive-her2-negative-advanced-breast-cancer-33333https://curecurrent.com/trials/effects-of-yoga-in-breast-cancer-patients-33334https://curecurrent.com/trials/blood-sample-collection-to-evaluate-biomarkers-in-subjects-with-untreated-solid-tumors-33335https://curecurrent.com/trials/mindfulness-relaxation-compared-with-relaxing-music-and-standard-symptom-management-education-in-treating-patients-who-a-33336https://curecurrent.com/trials/genetically-modified-t-cell-therapy-in-treating-patients-with-advanced-ror1-malignancies-33337https://curecurrent.com/trials/a-study-on-the-effectiveness-of-wechat-based-online-education-to-reduce-perioperative-anxiety-in-breast-cancer-patients-33338https://curecurrent.com/trials/meditation-and-cognitive-function-in-women-with-breast-cancer-33339https://curecurrent.com/trials/study-evaluating-hot-flashes-in-hormone-sensitive-breast-cancer-33340https://curecurrent.com/trials/a-phase-1b-2-trial-evaluating-safety-and-efficacy-of-capecitabine-in-combination-with-ni-raparib-in-her2-negative-advanc-33341https://curecurrent.com/trials/palbociclib-with-everolimus-exemestane-in-bc-33342https://curecurrent.com/trials/extended-cancer-education-for-longer-term-survivors-in-primary-care-for-patients-with-stage-i-ii-breast-or-prostate-canc-33343https://curecurrent.com/trials/acupuncture-for-joint-symptoms-in-patients-with-breast-cancer-33344https://curecurrent.com/trials/radiofrequency-chip-for-localization-of-non-palpable-breast-lesions-33345https://curecurrent.com/trials/a-study-of-atezolizumab-tecentriq-in-ministry-of-food-and-drug-safety-mfds-approved-indication-s-33346https://curecurrent.com/trials/metabolic-sodium-mri-to-assess-early-response-of-breast-cancer-to-neoadjuvant-chemotherapy-33347https://curecurrent.com/trials/mindfulness-based-couples-therapy-33348https://curecurrent.com/trials/minimal-invasive-axillary-staging-and-treatment-after-neoadjuvant-systemic-therapy-in-node-positive-breast-cancer-33349https://curecurrent.com/trials/individualizing-surveillance-mammography-for-older-breast-cancer-survivors-33350https://curecurrent.com/trials/application-of-preoperative-axillary-lymph-node-marking-with-nano-carbon-in-breast-cancer-patients-before-neoadjuvant-ch-33351https://curecurrent.com/trials/onc201-in-recurrent-refractory-metastatic-breast-cancer-and-advanced-endometrial-carcinoma-33352https://curecurrent.com/trials/neoadjuvant-dalpiciclib-plus-letrozole-for-hr-her2-breast-cancer-33353https://curecurrent.com/trials/dalpiciclib-combined-with-letrozole-in-neoadjuvant-treatment-of-stage-hr-positive-her2-negative-breast-cancer-33354https://curecurrent.com/trials/effectiveness-of-care-in-certified-cancer-centres-in-germany-33355https://curecurrent.com/trials/azd4547-anastrozole-or-letrozole-nsais-in-er-breast-cancer-patients-who-have-progressed-on-nsais-radical-33356https://curecurrent.com/trials/taselisib-and-enzalutamide-in-treating-patients-with-androgen-receptor-positive-triple-negative-metastatic-breast-cancer-33357https://curecurrent.com/trials/incidence-and-prognostic-significance-of-her-2-status-discordance-between-primary-breast-cancer-and-paired-recurrent-met-33358https://curecurrent.com/trials/music-intervention-for-preoperative-anxiety-and-acute-pain-among-mastectomy-patients-33359https://curecurrent.com/trials/cyp2d6-genotypes-and-breast-cancer-clinical-outcomes-in-the-indonesian-population-33360https://curecurrent.com/trials/a-study-comparing-two-standard-of-care-adjuvant-chemotherapy-regimens-for-lower-risk-her-2-positive-breast-cancer-33361https://curecurrent.com/trials/microwave-radiometry-for-the-diagnosis-and-monitoring-of-breast-cancer-33362https://curecurrent.com/trials/a-phase-i-multicenter-open-label-multi-part-dose-escalation-study-of-rad1901-in-postmenopausal-women-with-advanced-estro-33363https://curecurrent.com/trials/study-on-the-safety-and-efficacy-of-autogenous-tumor-infiltrates-lymphocytes-for-the-treatment-of-advanced-breast-cancer-33364https://curecurrent.com/trials/a-safety-and-activity-study-of-sbt6050-in-combination-with-other-her2-directed-therapies-for-her2-positive-cancers-33365https://curecurrent.com/trials/a-study-of-gene-edited-autologous-neoantigen-targeted-tcr-t-cells-with-or-without-anti-pd-1-in-patients-with-solid-tumor-33366https://curecurrent.com/trials/phase-ib-study-to-evaluate-rad1901-on-the-availability-of-estrogen-receptor-binding-sites-in-metastatic-breast-cancer-33367https://curecurrent.com/trials/life-style-modification-for-breast-canccer-survivors-using-mobile-app-based-human-coaching-program-33368https://curecurrent.com/trials/gb1275-monotherapy-and-in-combination-with-an-anti-pd1-antibody-in-patients-with-specified-advanced-solid-tumors-or-in-c-33369https://curecurrent.com/trials/phase-1-first-in-human-study-of-rad140-in-postmenopausal-women-with-breast-cancer-33370https://curecurrent.com/trials/a-phase-ib-study-of-hs-10352-plus-fulvestrant-in-patients-with-advanced-breast-cancer-33371https://curecurrent.com/trials/ttac-0001-and-pembrolizumab-phase-ib-combination-trial-in-metastatic-triple-negative-breast-cancer-33372https://curecurrent.com/trials/ice-sense-cryotherapy-for-breast-fibroadenoma-trial-33373https://curecurrent.com/trials/metformin-and-omega-3-fatty-acids-in-woman-with-a-history-of-early-stage-breast-cancer-33374https://curecurrent.com/trials/ability-of-l-carnitine-to-prevent-heart-damage-in-breast-cancer-patients-receiving-anthracycline-chemotherapy-33375https://curecurrent.com/trials/phosphatidylinositol-3-kinase-pi3k-alpha-inhibition-in-advanced-breast-cancer-33376https://curecurrent.com/trials/breast-cancer-with-intraoperative-radiotherapy-followed-by-hypofractionated-external-beam-radiotherapy-33377https://curecurrent.com/trials/a-window-of-opportunity-study-of-pelareorep-in-early-breast-cancer-33378https://curecurrent.com/trials/effect-of-radiotherapy-variables-on-circulating-effectors-of-immune-response-and-local-microbiome-33379https://curecurrent.com/trials/evaluation-of-a-3-d-tomosynthesis-mammography-system-used-in-conjunction-with-conventional-2-d-digital-mammography-33380https://curecurrent.com/trials/a-trial-of-shr-1210-an-anti-pd-1-inhibitor-in-combination-with-apatinib-and-fluzoparib-in-patients-with-tnbc-33381https://curecurrent.com/trials/mrx0518-in-patients-with-solid-tumours-waiting-surgical-removal-of-the-tumour-33382https://curecurrent.com/trials/comparison-of-two-combination-chemotherapy-regimens-in-treating-women-with-breast-cancer-33383https://curecurrent.com/trials/breast-cancer-liquid-biopsy-trial-33384https://curecurrent.com/trials/a-phase-1b-study-of-zn-c5-in-chinese-subjects-33385https://curecurrent.com/trials/a-study-of-neoadjuvant-nivolumab-palbociclib-anastrozole-in-post-menopausal-women-and-men-with-primary-breast-cancer-33386https://curecurrent.com/trials/fuscc-refractory-tnbc-umbrella-future-33387https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-the-p2et-extract-in-patients-with-breast-cancer-33388https://curecurrent.com/trials/effects-of-stellate-ganglion-block-on-hot-flashes-in-hispanic-women-with-breast-cancer-33389https://curecurrent.com/trials/phenotype-and-prognosis-of-patients-with-breast-cancer-and-pathogenic-variants-of-tp53-33390https://curecurrent.com/trials/complications-after-lumpectomy-sentinel-node-and-radiotherapy-in-breast-cancer-patients-and-physiotherapy-care-33391https://curecurrent.com/trials/the-relationship-between-the-differences-in-blood-cytokine-values-in-breast-cancers-33392https://curecurrent.com/trials/home-based-exercise-for-patients-with-breast-or-prostate-cancer-the-benefit-ca-study-33393https://curecurrent.com/trials/observational-analysis-of-palbociclib-treatment-in-patients-with-first-line-therapy-for-locally-advanced-and-or-metastat-33394https://curecurrent.com/trials/hypofractionated-radiotherapy-in-breast-cancer-patients-with-prosthetic-reconstruction-33395https://curecurrent.com/trials/local-therapy-for-er-pr-positive-oligometastatic-breast-cancer-33396https://curecurrent.com/trials/antioxidant-supplements-genetics-and-chemotherapy-outcomes-33397https://curecurrent.com/trials/treatment-patterns-of-neratinib-in-her2-ebc-in-china-33398https://curecurrent.com/trials/to-evaluate-the-efficacy-of-toripalimab-combined-with-chemotherapy-after-hifu-induction-in-the-treatment-of-early-triple-33399https://curecurrent.com/trials/comparing-the-quality-of-analgesia-with-pectoral-nerve-block-and-serratus-plane-block-in-modified-radical-mastectomy-33400https://curecurrent.com/trials/a-study-of-immunotherapy-combined-with-neoadjuvant-therapy-versus-neoadjuvant-therapy-for-breast-cancer-33401https://curecurrent.com/trials/doxorubicin-and-cyclophosphamide-followed-by-trastuzumab-paclitaxel-and-lapatinib-in-treating-patients-with-early-stage-33402https://curecurrent.com/trials/the-effect-of-a-patient-decision-aids-for-breast-cancer-screening-33403https://curecurrent.com/trials/accelerated-partial-breast-irradiation-apbi-using-stereotactic-body-radiation-therapy-sbrt-33404https://curecurrent.com/trials/rapidplan-models-establishment-for-node-positive-breast-cancer-treated-with-hypofractionation-using-edge-truebeam-33405https://curecurrent.com/trials/effectiveness-of-aerobic-exercises-and-laughter-yoga-compared-with-yoga-in-anxiety-depression-levels-in-breast-cancer-33406https://curecurrent.com/trials/bevacizumab-plus-paclitaxel-optimization-study-with-interventional-aintenance-endocrine-therapy-in-breast-cancer-33407https://curecurrent.com/trials/efficacy-and-safety-evaluating-study-of-ct-p6-in-her2-positive-early-breast-cancer-33408https://curecurrent.com/trials/external-vacuum-expansion-evaluation-in-breast-reconstructive-surgery-evaluation-in-breast-reconstructive-surgery-33409https://curecurrent.com/trials/bicalutamide-in-treating-patients-with-metastatic-breast-cancer-33410https://curecurrent.com/trials/ph3-study-to-determine-safety-tolerability-tumor-response-of-oraxol-compared-to-taxol-in-metastatic-breast-cancer-33411https://curecurrent.com/trials/preoperative-regional-nerve-block-for-acute-and-chronic-post-operative-pain-following-mastectomy-33412https://curecurrent.com/trials/brain-irradiation-and-tremelimumab-in-metastatic-breast-cancer-33413https://curecurrent.com/trials/phase-i-ii-study-of-pdr001-in-patients-with-advanced-malignancies-33414https://curecurrent.com/trials/infrared-imaging-for-breast-cancer-modeling-33415https://curecurrent.com/trials/pyrotinib-maleate-cdk4-6-inhibitor-and-letrozole-in-combination-for-stage-ii-iii-tpbc-a-phase-ii-trial-33416https://curecurrent.com/trials/magnesium-sulphate-to-bupivicaine-in-serratus-anterior-plane-block-in-modified-radical-mastectomy-33417https://curecurrent.com/trials/an-efficacy-study-of-the-xoft-axxent-ebx-iort-system-lite-33418https://curecurrent.com/trials/an-open-label-phase-ib-ii-clinical-trial-of-cdk-4-6-inhibitor-ribociclib-lee011-in-combination-with-trastuzumab-or-t-dm1-33419https://curecurrent.com/trials/phase-i-ib-trial-of-lsz102-single-agent-or-lsz102-lee011-or-lsz102-byl719-in-er-breast-cancers-33420https://curecurrent.com/trials/assessment-of-candidate-protein-expression-in-breast-cancer-specimens-33421https://curecurrent.com/trials/a-study-of-zn-c5-in-participants-with-breast-cancer-33422https://curecurrent.com/trials/study-of-eryaspase-in-combination-with-chemotherapy-versus-chemotherapy-alone-for-the-treatment-of-tnbc-trybeca-2-33423https://curecurrent.com/trials/patient-centered-communication-about-healthy-weight-in-early-breast-cancer-33424https://curecurrent.com/trials/effect-of-zoledronic-acid-treatment-on-bone-related-events-in-breast-cancer-patients-with-bone-metastases-a-prospective-33425https://curecurrent.com/trials/effect-of-low-dose-esketamine-on-postoperative-depression-in-patients-with-breast-cancer-33426https://curecurrent.com/trials/evaluation-of-impact-of-sandostatin-injection-before-axillary-clearance-on-lymphocele-formation-33427https://curecurrent.com/trials/erector-spinae-plane-block-versus-paravertebral-block-33428https://curecurrent.com/trials/functional-magnetic-resonance-imaging-in-assessing-affect-reactivity-and-regulation-in-patients-with-stage-0-iii-breast-33429https://curecurrent.com/trials/palbociclib-in-combination-with-letrozole-as-treatment-of-post-menopausal-women-with-hr-her2-advanced-breast-cancer-33430https://curecurrent.com/trials/docetaxel-ethanol-induced-symptoms-the-incidence-and-risk-forecating-factor-33431https://curecurrent.com/trials/lut014-for-the-treatment-of-radiation-induced-dermatitis-in-breast-cancer-patients-33432https://curecurrent.com/trials/a-study-to-assess-the-tolerability-and-clinical-activity-of-gedatolisib-in-combination-with-palbociclib-letrozole-or-pal-33433https://curecurrent.com/trials/support-program-for-adoption-of-cancer-screening-interventions-at-a-rural-community-based-organization-33434https://curecurrent.com/trials/molecularly-targeted-umbrella-study-in-luminal-advanced-breast-cancer-33435https://curecurrent.com/trials/improving-survivorship-among-minority-cancer-dyads-33436https://curecurrent.com/trials/olaparib-treatment-in-relapsed-germline-breast-cancer-susceptibility-gene-brca-mutated-ovarian-cancer-patients-who-have-33437https://curecurrent.com/trials/histology-of-functional-density-in-postmenopausal-breast-33438https://curecurrent.com/trials/neoadjuvant-immunotherapy-in-brain-metastases-33439https://curecurrent.com/trials/body-warming-in-improving-blood-flow-and-oxygen-delivery-to-tumors-in-patients-with-cancer-33440https://curecurrent.com/trials/phase-i-study-of-mln0128-and-mln8237-in-patients-with-advanced-solid-tumors-and-metastatic-triple-negative-breast-cancer-33441https://curecurrent.com/trials/dalpiciclib-plus-letrozole-and-capecitabine-33442https://curecurrent.com/trials/monitoring-of-breast-cancers-treated-by-neoadjuvant-radiotherapy-via-magnetic-resonance-imaging-33443https://curecurrent.com/trials/exploring-the-role-of-serum-methylmalonic-acid-mma-in-breast-cancer-33444https://curecurrent.com/trials/a-study-to-evaluate-gemcitabine-plus-cisplatin-in-the-treatment-of-tnbc-patients-following-neoadjuvant-chemotherapy-33445https://curecurrent.com/trials/somatic-acupressure-for-symptom-cluster-management-in-breast-cancer-patients-33446https://curecurrent.com/trials/inflammatory-blood-markers-in-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-33447https://curecurrent.com/trials/the-characteristics-and-risk-factors-of-breast-cancer-patients-trend-distinctive-regional-differences-a-cross-sectional-33448https://curecurrent.com/trials/prolonged-nightly-fasting-in-breast-cancer-survivors-33449https://curecurrent.com/trials/mindfulness-meditation-or-survivorship-education-in-improving-behavioral-symptoms-in-younger-stage-0-iii-breast-cancer-s-33450https://curecurrent.com/trials/clinical-trial-of-the-use-of-bolus-in-post-mastectomy-irradiation-in-breast-cancer-33451https://curecurrent.com/trials/acupuncture-for-hot-flashes-in-patients-with-hormone-receptor-positive-breast-cancer-33452https://curecurrent.com/trials/feasibility-study-of-accelerated-preoperative-radiotherapy-for-early-breast-cancer-33453https://curecurrent.com/trials/pet-mr-radiomics-for-breast-cancer-diagnosis-33454https://curecurrent.com/trials/taiwan-cancer-moonshot-project-33455https://curecurrent.com/trials/safety-pharmacodynamics-pharmacokinetics-and-efficacy-of-tomivosertib-combined-with-paclitaxel-in-advanced-breast-cancer-33456https://curecurrent.com/trials/study-of-the-glutaminase-inhibitor-cb-839-in-solid-tumors-33457https://curecurrent.com/trials/comparative-effectiveness-of-acupuncture-and-nonsteroidal-anti-inflammatory-drugs-for-the-management-of-aromatase-inhibi-33458https://curecurrent.com/trials/psychometric-properties-of-the-updated-module-on-assessing-quality-of-life-of-patients-with-breast-cancer-33459https://curecurrent.com/trials/a-study-of-atezolizumab-in-combination-with-nab-paclitaxel-compared-with-placebo-with-nab-paclitaxel-for-participants-wi-33460https://curecurrent.com/trials/assessing-efficacy-of-carboplatin-and-atezolizumab-in-metastatic-lobular-breast-cancer-33461https://curecurrent.com/trials/classified-treatment-strategy-for-de-novo-metastatic-breast-cancer-after-systemic-adjuvant-therapy-33462https://curecurrent.com/trials/study-of-the-safety-tolerability-and-efficacy-of-metabolic-combination-treatments-on-cancer-33463https://curecurrent.com/trials/phase-ii-study-of-niraparib-in-metastatic-tnbc-patients-with-homologous-recombination-deficiency-33464https://curecurrent.com/trials/a-feasibility-study-of-niraparib-for-advanced-brca1-like-her2-negative-breast-cancer-patients-33465https://curecurrent.com/trials/mindfulness-yoga-and-sexual-functioning-33466https://curecurrent.com/trials/dose-escalation-study-of-hbi-8000-in-combination-with-paclitaxel-and-trastuzumab-in-women-with-advanced-or-metastatic-he-33467https://curecurrent.com/trials/177lu-dtpa-omburtamab-radioimmunotherapy-for-leptomeningeal-metastasis-from-solid-tumors-breast-nsclc-malignant-melanoma-33468https://curecurrent.com/trials/ethnic-predisposition-risk-factors-breast-cancer-presentation-33469https://curecurrent.com/trials/evaluation-and-re-evaluation-of-post-mastectomy-pain-syndrome-by-breast-cancer-edge-task-force-outcomes-33470https://curecurrent.com/trials/the-added-value-of-a-third-supervised-training-session-to-a-standard-12-week-rehabilitation-program-after-breast-cancer-33471https://curecurrent.com/trials/evaluation-of-bnp7787-for-the-prevention-of-neurotoxicity-in-metastatic-breast-cancer-patients-receiving-weekly-paclitax-33472https://curecurrent.com/trials/incidence-and-resolution-of-eribulin-induced-peripheral-neuropathy-33473https://curecurrent.com/trials/a-whole-food-plant-based-nutrition-intervention-in-women-with-metastatic-breast-cancer-33474https://curecurrent.com/trials/construction-and-effect-evaluation-of-malignant-fungating-wounds-care-regimen-for-breast-cancer-patients-33475https://curecurrent.com/trials/assessment-of-brain-cognitive-impairment-in-breast-cancer-33476https://curecurrent.com/trials/short-and-long-term-effects-of-a-physical-therapy-program-after-breast-cancer-surgery-33477https://curecurrent.com/trials/a-study-of-taselisib-fulvestrant-versus-placebo-fulvestrant-in-participants-with-advanced-or-metastatic-breast-cancer-wh-33478https://curecurrent.com/trials/ak105-plus-anlotinib-hydrochloride-combined-with-albumin-paclitaxel-as-a-first-line-therapy-in-patients-with-advanced-tr-33479https://curecurrent.com/trials/carvedilol-for-the-prevention-of-anthracycline-anti-her2-therapy-associated-cardiotoxicity-among-women-with-her2-positiv-33480https://curecurrent.com/trials/incorporating-eprognosis-for-the-encouragement-of-smarter-screening-for-breast-and-colorectal-cancer-in-older-adults-33481https://curecurrent.com/trials/postoperative-radiation-of-patients-with-breast-cancer-in-extreme-hypofractionation-33482https://curecurrent.com/trials/margetuximab-plus-tucatinib-and-capecitabine-in-her2-positive-metastatic-breast-cancer-33483https://curecurrent.com/trials/lidocaine-versus-duloxetine-for-the-prevention-of-taxane-induced-peripheral-neuropathy-in-breast-cancer-patients-33484https://curecurrent.com/trials/civo-intratumoural-microdosing-of-anti-cancer-therapies-in-australia-33485https://curecurrent.com/trials/opioid-free-anaesthesia-in-oncologic-gynaecological-surgery-is-there-any-benefit-33486https://curecurrent.com/trials/dexmedetomidine-versus-dexamethasone-as-adjuncts-in-erector-spinae-plane-block-in-modified-radical-mastectomy-33487https://curecurrent.com/trials/utilizing-social-contacts-to-facilitate-mammogram-screening-among-african-american-women-33488https://curecurrent.com/trials/talazoparib-before-standard-therapy-in-treating-patients-with-invasive-brca-mutated-breast-cancer-33489https://curecurrent.com/trials/gut-microbiome-components-predict-response-to-neoadjuvant-therapy-in-her2-positive-breast-cancer-patients-a-prospective-33490https://curecurrent.com/trials/this-is-a-multicenter-randomized-double-blind-placebo-controlled-phase-iii-clinical-study-evaluating-the-efficacy-and-sa-33491https://curecurrent.com/trials/eribulin-mesylate-and-everolimus-in-treating-patients-with-triple-negative-metastatic-breast-cancer-33492https://curecurrent.com/trials/this-is-a-multicenter-randomized-double-blind-placebo-controlled-phase-iii-clinical-study-evaluating-the-efficacy-and-sa-33493https://curecurrent.com/trials/an-expanded-access-study-to-provide-at-home-subcutaneous-administration-of-pertuzumab-and-trastuzumab-fixed-dose-combina-33494https://curecurrent.com/trials/a-web-based-tool-to-improve-breast-cancer-survivorship-33495https://curecurrent.com/trials/pyrotinib-plus-vinorelbine-versus-lapatinib-plus-capecitabine-33496https://curecurrent.com/trials/antidepressant-efficacy-of-psychotherapy-and-citalopram-in-patients-with-breast-cancer-and-major-depression-33497https://curecurrent.com/trials/mepitel-film-treatment-for-the-prevention-and-cutaneous-toxicity-due-to-radiotherapy-33498https://curecurrent.com/trials/multi-center-study-of-deep-learning-ai-in-breast-mass-33499https://curecurrent.com/trials/a-study-for-the-adjuvant-treatment-of-breast-cancer-33500https://curecurrent.com/trials/topaz-tucatinib-in-combination-with-pembrolizumab-and-trastuzumab-in-patients-with-her2-positive-breast-cancer-brain-met-33501https://curecurrent.com/trials/89zr-atezolizumab-pet-scan-and-lobular-breast-cancer-33502https://curecurrent.com/trials/construction-and-validation-of-an-assessment-model-of-pcr-after-nat-on-breast-cancer-patients-with-ai-technology-33503https://curecurrent.com/trials/a-study-for-the-neoadjuvant-treatment-of-breast-cancer-33504https://curecurrent.com/trials/a-study-of-fluzoparib-given-in-combination-with-apatinib-in-ovarian-or-breast-cancer-patients-33505https://curecurrent.com/trials/study-of-sm-88-in-advanced-cancers-33506https://curecurrent.com/trials/imaging-the-patterns-of-breast-cancer-early-metastases-33507https://curecurrent.com/trials/quality-of-life-in-metastatic-breast-cancer-mbc-patients-in-second-line-monochemotherapy-33508https://curecurrent.com/trials/comparison-of-use-of-indocyanine-green-and-99mtc-labeled-radiotracer-for-axillary-lymphatic-mapping-in-patients-with-bre-33509https://curecurrent.com/trials/a-study-of-sbt6050-alone-and-in-combination-with-pd-1-inhibitors-in-subjects-with-advanced-her2-expressing-solid-tumors-33510https://curecurrent.com/trials/orteronel-as-monotherapy-in-patients-with-metastatic-breast-cancer-mbc-that-expresses-the-androgen-receptor-ar-33511https://curecurrent.com/trials/effect-of-laughter-therapy-on-perceived-stress-and-quality-of-life-33512https://curecurrent.com/trials/a-clinical-study-of-the-efficacy-and-safety-of-chidamide-in-combination-with-camrelizumab-and-carboplatin-or-capecitabin-33513https://curecurrent.com/trials/study-of-the-effect-of-the-addition-of-sndx-275-entinostat-to-continued-aromatase-inhibitor-ai-therapy-in-postmenopausal-33514https://curecurrent.com/trials/effect-of-nurse-led-supportive-care-on-quality-of-life-33515https://curecurrent.com/trials/phase-1b-multi-indication-study-of-anetumab-ravtansine-in-mesothelin-expressing-advanced-solid-tumors-33516https://curecurrent.com/trials/predictors-for-response-to-dose-dense-docetaxel-and-epirubicin-breast-cancer-33517https://curecurrent.com/trials/to-enhance-breast-cancer-survivorship-of-asian-americans-33518https://curecurrent.com/trials/surgical-pre-habilitation-in-breast-cancer-33519https://curecurrent.com/trials/a-phase-ii-study-comparing-the-efficacy-of-venetoclax-fulvestrant-vs-fulvestrant-in-women-with-estrogen-receptor-positiv-33520https://curecurrent.com/trials/efficacy-of-digital-breast-tomosynthesis-standard-2-dimensional-mammography-in-breast-cancer-33521https://curecurrent.com/trials/19f-hot-spot-mri-of-human-adipose-derived-stem-cells-for-breast-reconstruction-33522https://curecurrent.com/trials/breast-cancer-outreach-among-primary-care-patients-33523https://curecurrent.com/trials/the-efficacy-and-safety-of-dalpiciclib-plus-endocrine-therapy-in-hr-positive-her2-negative-advanced-breast-cancer-patien-33524https://curecurrent.com/trials/comparison-of-68ga-gafapi-46-pet-ct-and-18f-fdg-pet-ct-findings-in-breast-carcinoma-33525https://curecurrent.com/trials/pilot-study-of-the-predictive-value-of-trem1-expression-and-activation-in-inflammation-and-radio-induced-mammary-fibrosi-33526https://curecurrent.com/trials/precise-therapy-for-refractory-her2-positive-advanced-breast-cancer-33527https://curecurrent.com/trials/novel-double-target-therapy-combined-with-chemotherapy-in-first-line-treatment-of-her2-breast-cancer-ma-bc-ii-038-33528https://curecurrent.com/trials/healing-touch-during-chemotherapy-infusions-for-women-with-breast-cancer-33529https://curecurrent.com/trials/guardant360-related-clinical-outcomes-in-patients-who-share-medical-records-breast-cancer-33530https://curecurrent.com/trials/circulating-tumor-dna-ctdna-guided-late-line-treatment-in-patients-with-late-stage-breast-cancer-33531https://curecurrent.com/trials/lumpectomy-specimen-margin-evaluation-with-tomography-and-structured-light-imaging-33532https://curecurrent.com/trials/study-of-kn026-in-combination-with-docetaxel-as-neoadjuvant-therapy-in-her2-positive-breast-cancer-33533https://curecurrent.com/trials/magnetic-marker-localization-for-occult-breast-cancer-and-target-axillary-dissection-in-node-positive-breast-cancer-post-33534https://curecurrent.com/trials/clinical-application-of-circulating-tumor-dna-ctdna-in-patients-with-late-stage-breast-cancer-33535https://curecurrent.com/trials/study-of-khk2375-in-subjects-with-advanced-or-recurrent-breast-cancer-33536https://curecurrent.com/trials/radiation-therapy-in-treating-women-with-locally-recurrent-breast-cancer-previously-treated-with-repeat-breast-preservin-33537https://curecurrent.com/trials/breast-cancer-neoantigen-vaccination-with-autologous-dendritic-cells-33538https://curecurrent.com/trials/molecular-mechanisms-of-resistance-and-sensitivity-to-palbociclib-re-challenge-in-er-mbc-33539https://curecurrent.com/trials/phase-2-study-of-khk2375-in-subjects-with-advanced-or-recurrent-breast-cancer-33540https://curecurrent.com/trials/droplet-bc-screening-test-for-the-detection-of-breast-cancer-the-droplet-bc-study-33541https://curecurrent.com/trials/validation-of-the-russian-and-kazakh-versions-of-the-beck-depression-inventory-and-beck-anxiety-inventory-33542https://curecurrent.com/trials/the-role-of-lipofilling-after-oncoplastic-breast-surgeries-evaluation-of-outcomes-and-patient-satisfaction-33543https://curecurrent.com/trials/trial-of-sacituzumab-govitecan-in-participants-with-refractory-relapsed-metastatic-triple-negative-breast-cancer-tnbc-33544https://curecurrent.com/trials/refusal-of-breast-surgery-in-patients-with-breast-cancer-with-a-clinical-complete-response-ccr-after-neoadjuvant-systemi-33545https://curecurrent.com/trials/investigating-atezolizumab-in-newly-diagnosed-er-positive-breast-cancer-patients-according-to-their-adiposity-33546https://curecurrent.com/trials/phase-i-study-of-the-hs-10352-in-patients-with-advanced-breast-cancer-33547https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-kadcyla-plus-pertuzumab-perjeta-following-anthracyclines-in-comparison-with-trastuzumab-33548https://curecurrent.com/trials/effectiveness-of-cryotherapy-combined-with-compression-therapy-for-preventing-chemotherapy-induced-peripheral-neuropathy-33549https://curecurrent.com/trials/assessing-the-sensitivity-of-suretouch-in-women-undergoing-diagnostic-and-screening-mammography-33550https://curecurrent.com/trials/pazopanib-in-combination-with-capecitabine-in-patients-with-metastatic-breast-cancer-33551https://curecurrent.com/trials/clinical-study-of-68ga-labeled-her2-affibody-analogues-33552https://curecurrent.com/trials/cryoablation-combined-with-tirelizumab-and-bevacizumab-in-liver-metastatic-tnbc-patients-failed-by-multiline-therapy-33553https://curecurrent.com/trials/effects-of-ribociclib-and-palbociclib-on-tumor-and-blood-characteristics-in-patients-with-metastatic-breast-cancer-33554https://curecurrent.com/trials/volatile-anaesthesia-and-perioperative-outcomes-related-to-cancer-feasibility-study-33555https://curecurrent.com/trials/molecular-profile-of-breast-cancer-in-ugandan-patients-with-stage-iib-iii-breast-cancer-33556https://curecurrent.com/trials/cognitive-stimulation-and-chemobrain-an-innovative-intervention-for-cancer-survivors-33557https://curecurrent.com/trials/study-of-quality-of-life-post-salpingo-oophorectomy-in-brca1-2-palb2-mutation-carriers-brca-hrt-33558https://curecurrent.com/trials/sexual-and-vaginal-health-in-breast-cancer-women-receiving-aromatase-inhibitors-before-and-after-co2-laser-therapy-33559https://curecurrent.com/trials/byl719-and-nab-paclitaxel-in-locally-recurrent-or-metastatic-her-2-negative-breast-cancer-33560https://curecurrent.com/trials/a-phase-i-multicenter-open-label-study-on-the-effects-of-sndx-275-on-expression-of-biomarkers-in-subjects-with-newly-dia-33561https://curecurrent.com/trials/clinical-study-of-chidamide-combined-with-chemotherapy-in-neoadjuvant-treatment-of-hr-her2-bc-33562https://curecurrent.com/trials/exercise-and-nutrition-education-in-improving-physical-function-and-quality-of-life-in-older-breast-cancer-survivors-33563https://curecurrent.com/trials/the-impact-of-a-web-based-patient-decision-aid-for-women-considering-breast-reconstruction-33564https://curecurrent.com/trials/weekly-utidelone-in-her2-negative-inoperable-locally-advanced-or-metastatic-breast-cancer-33565https://curecurrent.com/trials/window-of-opportunity-trial-of-dasatinib-in-operable-triple-negative-breast-cancers-with-negfr-33566https://curecurrent.com/trials/radiation-therapy-hb-001-by-alpha-particle-sources-for-recurrent-malignant-solid-tumors-in-japan-33567https://curecurrent.com/trials/combined-modality-exercise-and-appetite-in-breast-cancer-survivors-33568https://curecurrent.com/trials/evaluation-of-contrast-enhanced-breast-ct-for-diagnosis-and-staging-of-breast-cancer-33569https://curecurrent.com/trials/hypofractionated-irradiation-at-regional-nodal-area-for-breast-cancer-vs-existed-standard-treatment-33570https://curecurrent.com/trials/real-time-tele-monitoring-versus-routine-monitoring-of-breast-cancer-patients-receiving-adjuvant-systemic-therapy-33571https://curecurrent.com/trials/study-of-eribulin-in-combination-with-anti-pd-1-antibody-in-patients-with-metastatic-triple-negative-breast-cancer-33572https://curecurrent.com/trials/study-to-identify-molecular-mechanisms-of-clinical-resistance-to-chemotherapy-in-triple-negative-breast-cancer-patients-33573https://curecurrent.com/trials/acupuncture-in-reducing-chemotherapy-induced-peripheral-neuropathy-in-participants-with-stage-i-iii-breast-cancer-33574https://curecurrent.com/trials/a-study-of-niraparib-combined-with-mgd013-in-patients-with-advanced-or-metastatic-solid-tumor-who-failed-prior-treatment-33575https://curecurrent.com/trials/study-of-the-anti-tumoral-immune-response-33576https://curecurrent.com/trials/arx788-in-her2-positive-breast-cancer-patients-with-brain-metastases-33577https://curecurrent.com/trials/breast-cancer-and-kinesiophobia-and-physical-activity-33578https://curecurrent.com/trials/supervised-exercise-sleep-in-patients-with-non-metastatic-breast-cancer-33579https://curecurrent.com/trials/aromatase-inhibitor-and-durvalumab-in-postmenopausal-breast-cancer-33580https://curecurrent.com/trials/risk-factors-for-shoulder-joint-motion-restriction-33581https://curecurrent.com/trials/comparison-of-two-schedules-of-zoledronic-acid-in-treating-patients-with-breast-cancer-that-has-spread-to-the-bone-33582https://curecurrent.com/trials/1303gcc-trastuzmab-pertuzumab-with-hormonal-therapy-or-chemotherapy-in-women-aged-60-and-over-33583https://curecurrent.com/trials/protocol-for-herceptin-as-adjuvant-therapy-with-reduced-exposure-to-chemotherapy-phare-c-33584https://curecurrent.com/trials/dosimetric-comparison-of-three-radiation-techniques-for-hypofractionated-whole-breast-radiotherapy-in-early-breast-cance-33585https://curecurrent.com/trials/outcomes-of-local-perforator-flaps-in-oncoplastic-surgery-33586https://curecurrent.com/trials/urtica-comp-gel-for-prevention-and-therapy-of-radiation-dermatitis-33587https://curecurrent.com/trials/comparing-the-performance-of-automated-breast-ultrasonography-to-hand-held-whole-breast-ultrasonography-in-breast-cancer-33588https://curecurrent.com/trials/novel-molecular-targets-for-ductal-carcinoma-in-situ-dcis-33589https://curecurrent.com/trials/ultrasound-tomography-using-softvue-in-diagnosing-women-with-breast-cancer-33590https://curecurrent.com/trials/consequences-of-eccentric-cycling-on-exercise-related-neuromuscular-responses-and-biomarkers-in-breast-cancer-patients-33591https://curecurrent.com/trials/t-dm1-with-or-without-abemaciclib-for-the-treatment-of-her2-positive-metastatic-breast-cancer-33592https://curecurrent.com/trials/anthracycline-induced-cardiotoxicity-early-detection-by-combination-of-diastolic-strain-and-t2-mapping-33593https://curecurrent.com/trials/sentinel-lymph-node-mapping-with-near-infrared-fluorescent-markers-33594https://curecurrent.com/trials/therapeutic-dose-monitoring-tdm-of-tamoxifen-33595https://curecurrent.com/trials/radiation-therapy-with-or-without-optional-tamoxifen-in-treating-women-with-ductal-carcinoma-in-situ-33596https://curecurrent.com/trials/pantoprazole-prophylaxis-against-delayed-cinv-for-patients-receiving-breast-cancer-chemotherapy-33597https://curecurrent.com/trials/breclim-2-a-rct-investigating-local-treatment-for-breast-cancer-liver-metastases-33598https://curecurrent.com/trials/synergic-effects-of-physical-activity-and-probiotic-on-gut-immune-system-and-quality-of-life-of-breast-cancer-survivors-33599https://curecurrent.com/trials/expanded-access-to-veliparib-33600https://curecurrent.com/trials/effect-of-chan-chuang-qigong-with-breathing-meditation-on-quality-of-life-in-patients-with-breast-cancer-33601https://curecurrent.com/trials/comparison-of-erector-spinae-plane-block-with-pecs-ii-block-in-patients-undergoing-breast-cancer-surgery-33602https://curecurrent.com/trials/diet-exercise-and-vitamin-d-in-breast-cancer-recurrence-33603https://curecurrent.com/trials/breast-reconstruction-following-breast-cancer-in-very-high-risk-patients-33604https://curecurrent.com/trials/evaluating-mepitel-in-post-mastectomy-patients-and-the-role-of-the-skin-microbiome-in-radiation-dermatitis-33605https://curecurrent.com/trials/micrima-maria-data-collection-for-machine-learning-study-33606https://curecurrent.com/trials/the-abc-study-assessment-of-breast-density-classification-33607https://curecurrent.com/trials/online-trial-examining-validity-and-reliability-of-the-shared-decision-making-process-survey-33608https://curecurrent.com/trials/prediction-of-18f-fes-pet-ct-parameters-on-palbociclib-combined-with-et-33609https://curecurrent.com/trials/neoadjuvant-therapy-in-clinical-stage-i-iii-her2-positive-breast-cancer-33610https://curecurrent.com/trials/phase-2-study-of-trastuzumab-and-etoposide-for-her2-positive-breast-cancer-33611https://curecurrent.com/trials/intratumoral-trimix-injections-in-early-breast-cancer-patients-33612https://curecurrent.com/trials/medi4736-and-tremelimumab-in-treating-patients-with-metastatic-her2-negative-breast-cancer-33613https://curecurrent.com/trials/endopredict-extended-endocrine-trial-exet-33614https://curecurrent.com/trials/myofascial-release-or-trigger-point-injections-for-the-reduction-of-post-mastectomy-pain-syndrome-33615https://curecurrent.com/trials/signal-during-a-covid-19-pandemic-33616https://curecurrent.com/trials/an-intervention-for-female-breast-cancer-acceptance-and-commitment-therapy-i-can-act-for-depression-and-physical-pain-33617https://curecurrent.com/trials/axillary-reverse-mapping-using-near-infrared-imaging-in-invasive-breast-cancer-predictors-of-nodal-positivity-33618https://curecurrent.com/trials/nb1011-administered-by-continuous-infusion-in-cancers-that-overexpress-thymidylate-synthase-ts-33619https://curecurrent.com/trials/study-of-euthyroid-hypothyroxinemia-in-metastatic-breast-carcinoma-33620https://curecurrent.com/trials/brain-stimulation-for-cancer-smokers-33621https://curecurrent.com/trials/study-on-the-correlation-between-the-quantitative-parameters-of-mr-mean-cell-size-imaging-and-the-histopathological-char-33622https://curecurrent.com/trials/integrated-care-pathway-in-oncology-passion-33623https://curecurrent.com/trials/ehr-embedded-ocdt-in-breast-or-gi-cancer-33624https://curecurrent.com/trials/study-to-evaluate-exemestane-with-and-without-entinostat-sndx-275-in-treatment-of-postmenopausal-women-with-advanced-bre-33625https://curecurrent.com/trials/single-fraction-intraoperative-radiotherapy-33626https://curecurrent.com/trials/intraoperative-boost-radiotherapy-with-electrons-ioert-followed-by-hypofractionated-whole-breast-irradiation-wbrt-33627https://curecurrent.com/trials/cardiac-safety-study-in-patients-with-her2-breast-cancer-33628https://curecurrent.com/trials/phase-ib-ii-study-of-ribociclib-with-trastuzumab-plus-letrozole-in-postmenopausal-hr-her2-advanced-breast-cancer-patient-33629https://curecurrent.com/trials/a-study-that-provides-long-term-safety-follow-up-and-examines-long-term-exposure-to-abiraterone-acetate-33630https://curecurrent.com/trials/one-week-adjuvant-radiotherapy-for-breast-cancer-33631https://curecurrent.com/trials/a-study-evaluating-near-infrared-zone-ii-imaging-in-sentinel-lymph-node-mapping-in-breast-cancer-patients-33632https://curecurrent.com/trials/a-study-for-optimization-of-6-hydroxyethyl-starch-based-indocyanine-green-near-infrared-fluorescence-navigated-sentinel-33633https://curecurrent.com/trials/adaptations-to-breast-cancer-and-exercise-33634https://curecurrent.com/trials/avoiding-growth-factor-during-paclitaxel-treatment-in-breast-cancer-33635https://curecurrent.com/trials/mifepristone-for-breast-cancer-patients-with-higher-levels-of-progesterone-receptor-isoform-a-than-isoform-b-33636https://curecurrent.com/trials/an-open-label-study-to-characterize-the-incidence-and-severity-of-diarrhea-in-patients-with-early-stage-her2-breast-canc-33637https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-eribulin-mesylate-in-combination-with-pembrolizumab-in-participants-with-me-33638https://curecurrent.com/trials/circulating-tumor-cell-detection-in-patients-with-luminal-a-breast-cancer-33639https://curecurrent.com/trials/evaluating-a-novel-web-based-intervention-for-breast-cancer-survivors-33640https://curecurrent.com/trials/chemotherapy-induced-circadian-rhythm-disruption-33641https://curecurrent.com/trials/assessment-of-left-sided-cardiac-sparing-through-the-use-of-3-dimensional-surface-matching-based-deep-inspiration-breath-33642https://curecurrent.com/trials/determinants-of-acquired-endocrine-resistance-in-metastatic-breast-cancer-a-pilot-study-33643https://curecurrent.com/trials/the-effect-of-the-motivational-interviewing-technique-on-breast-and-cervical-cancer-screenings-33644https://curecurrent.com/trials/stanford-accelerated-recovery-trial-start-33645https://curecurrent.com/trials/improvement-of-the-operative-outcome-in-patients-with-primary-vegf-unifocal-breast-cancer-or-dcis-through-the-intraopera-33646https://curecurrent.com/trials/the-effect-of-mobile-application-based-information-about-before-and-after-surgery-33647https://curecurrent.com/trials/study-on-sbrt-for-inoperable-lung-and-liver-oligometastases-from-breast-cancer-33648https://curecurrent.com/trials/cardiac-toxicity-of-hypo-fractionated-radiotherapy-in-left-breast-cancer-33649https://curecurrent.com/trials/assessment-of-sarcopenia-at-diagnosis-for-patients-with-previously-untreated-metastatic-cancer-or-hematologic-malignancy-33650https://curecurrent.com/trials/entinostat-and-anastrozole-in-treating-postmenopausal-women-with-tnbc-that-can-be-removed-by-surgery-33651https://curecurrent.com/trials/trial-of-amrubicin-as-treatment-for-patients-with-her2-negative-metastatic-breast-cancer-33652https://curecurrent.com/trials/randomized-controlled-trial-of-neo-adjuvant-progesterone-and-vitamin-d3-in-women-with-large-operable-breast-cancer-and-l-33653https://curecurrent.com/trials/palbociclib-trastuzumab-pyrotinib-and-fulvestrant-treatment-in-patients-with-brain-metastasis-from-er-pr-positive-her-2-33654https://curecurrent.com/trials/primary-radiotherapy-and-diep-flap-reconstruction-trial-33655https://curecurrent.com/trials/enhance-the-use-of-genetic-counseling-and-testing-in-latinas-33656https://curecurrent.com/trials/telerehabilitation-cognitive-impairments-following-chemotherapy-feasibility-study-33657https://curecurrent.com/trials/feasibility-and-accuracy-of-nanosensor-based-cancer-diagnosis-at-the-point-of-care-chedza-33658https://curecurrent.com/trials/medico-economic-study-of-three-strategies-of-sentinel-lymph-node-analysis-in-operable-breast-cancer-33659https://curecurrent.com/trials/comparative-effectiveness-of-palbociclib-plus-ai-versus-fulvestrant-for-hr-her2-abc-33660https://curecurrent.com/trials/ctc-in-predicting-neoadjuvant-chemotherapy-among-labc-patients-a-single-center-prospective-exploratory-clinical-trial-33661https://curecurrent.com/trials/efficacy-and-safety-of-sintilimab-and-apatinib-combined-chemotherapy-in-breast-cancer-33662https://curecurrent.com/trials/the-pai-trial-for-breast-and-colon-cancer-survivors-33663https://curecurrent.com/trials/telerehabilitation-cognitive-impairments-following-chemotherapy-usability-study-33664https://curecurrent.com/trials/trial-of-vinflunine-plus-capecitabine-in-advanced-breast-cancer-33665https://curecurrent.com/trials/cardiac-safety-study-of-entinostat-in-men-and-women-with-advanced-solid-tumors-33666https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacokinetics-of-abbv-368-as-a-single-agent-and-combination-in-subjects-with-l-33667https://curecurrent.com/trials/evaluation-of-tamoxifen-s-efficacy-for-er-pr-negative-er-beta-positive-operable-breast-cancer-patients-33668https://curecurrent.com/trials/understanding-patient-experience-and-preferences-for-the-qt-scanner-compared-to-mammography-33669https://curecurrent.com/trials/the-hifub-study-hifu-in-breast-cancer-33670https://curecurrent.com/trials/the-gut-microbiome-and-immune-checkpoint-inhibitor-therapy-in-solid-tumors-33671https://curecurrent.com/trials/pre-pectoral-versus-sub-pectoral-implant-placement-in-immediate-breast-reconstruction-33672https://curecurrent.com/trials/study-of-the-combination-of-kd019-and-trastuzumab-in-subjects-with-her2-positive-metastatic-breast-cancer-33673https://curecurrent.com/trials/preoperative-radiotherapy-and-systemic-therapy-following-surgery-in-de-novo-metastatic-breast-cancer-33674https://curecurrent.com/trials/pyrotinib-rechallenge-in-her2-positive-metastatic-breast-cancer-pretreated-with-pyrotinib-and-trastuzumab-33675https://curecurrent.com/trials/adopting-the-mrd-strategy-to-optimize-post-operation-adjuvant-therapies-for-early-stage-breast-cancer-33676https://curecurrent.com/trials/pyrotinib-plus-vinorelbine-in-participants-with-her2-positive-previously-treated-locally-advanced-or-metastatic-breast-c-33677https://curecurrent.com/trials/pld-cyclophosphamide-nab-p-continuously-combined-with-dual-her2-blockage-for-her2-positive-breast-cancer-33678https://curecurrent.com/trials/her2-positive-breast-cancer-project-initiated-by-investigators-33679https://curecurrent.com/trials/prone-positioning-ct-scan-and-ultrasound-assessing-axillary-lymph-nodes-in-patients-with-breast-cancer-official-title-ev-33680https://curecurrent.com/trials/lci-bre-mtn-nir-001-ph-i-study-of-niraparib-in-combo-with-standard-chemo-in-metastatic-trip-neg-breast-cancer-33681https://curecurrent.com/trials/the-effect-of-acupuncture-for-insomnia-in-breast-cancer-patients-undergoing-chemotherapy-33682https://curecurrent.com/trials/comparative-effectiveness-of-pal-based-therapy-as-initial-et-versus-pal-based-therapy-after-cht-for-hr-her2-abc-33683https://curecurrent.com/trials/immune-response-and-potential-booster-for-patients-who-have-received-her2-pulsed-dc1-33684https://curecurrent.com/trials/testing-an-intelligent-tutoring-system-to-enhance-genetic-risk-assessment-33685https://curecurrent.com/trials/sentinel-lymph-node-detection-after-neoadjuvant-chemotherapy-for-large-operable-breast-cancer-33686https://curecurrent.com/trials/sentinel-lymph-node-procedure-in-ipsilateral-invasive-breast-cancer-relapse-33687https://curecurrent.com/trials/clinical-trial-for-effect-of-tqb3616-capsule-on-pharmacokinetics-in-healthy-adult-subjects-33688https://curecurrent.com/trials/arx788-in-breast-cancer-with-low-expression-of-her2-33689https://curecurrent.com/trials/abx-plus-cisplatin-versus-gemcitabine-plus-cisplatin-in-triple-negative-breast-cancer-tnbc-33690https://curecurrent.com/trials/impact-of-neoadjuvant-hormonal-therapy-on-the-surgical-management-of-extensive-ductal-carcinomas-in-situ-33691https://curecurrent.com/trials/secondary-adjuvant-treatment-for-patients-with-isolated-tumor-cells-in-bone-marrow-33692https://curecurrent.com/trials/sentinel-lymph-node-after-neoadjuvant-chemotherapy-in-breast-carcinoma-33693https://curecurrent.com/trials/interest-of-touch-massage-in-hospital-day-care-33694https://curecurrent.com/trials/chemotherapy-induced-changes-to-cognition-and-dna-in-breast-cancer-survivors-33695https://curecurrent.com/trials/nipple-sparing-mastectomy-cosmetic-outcomes-33696https://curecurrent.com/trials/platinum-rechallenge-in-patients-with-platinum-sensitive-mtnbc-33697https://curecurrent.com/trials/the-effect-of-self-compassion-on-breast-cancer-33698https://curecurrent.com/trials/guided-treatment-based-on-mini-pdx-in-metastatic-triple-negative-breast-cancer-33699https://curecurrent.com/trials/immunobreast-a-phase-ib-study-33700https://curecurrent.com/trials/biological-and-clinical-effects-of-palbociclib-with-ovarian-suppression-and-letrozole-in-the-neoadjuvant-treatment-of-br-33701https://curecurrent.com/trials/metronomic-pld-in-patients-with-primary-endocrine-resistant-abc-33702https://curecurrent.com/trials/pd-1-programmed-death-1-antibody-gp-as-first-line-treatment-for-triple-negative-breast-cancer-tnbc-patients-33703https://curecurrent.com/trials/chidamide-combined-with-cisplatin-for-relapsed-or-metastatic-triple-negative-breast-cancer-33704https://curecurrent.com/trials/a-phase-ib-study-of-gb491-plus-letrozole-in-patients-with-advanced-breast-cancer-33705https://curecurrent.com/trials/effects-of-high-dose-calcitriol-in-breast-cancer-patients-33706https://curecurrent.com/trials/a-clinical-trial-comparing-the-combination-of-tc-plus-bevacizumab-to-tc-alone-and-to-tac-for-women-with-node-positive-or-33707https://curecurrent.com/trials/gemcitabine-plus-cisplatin-versus-gemcitabine-plus-carboplatin-in-triple-negative-breast-cancer-tnbc-33708https://curecurrent.com/trials/study-on-the-value-of-non-invasive-dual-pet-information-in-subtype-of-metastatic-breast-cancer-33709https://curecurrent.com/trials/adding-mirtazapine-to-dexamethasone-and-aprepitant-for-delayed-emesis-33710https://curecurrent.com/trials/artificial-intelligence-in-breast-cancer-screening-in-region-sterg-tland-linkoping-33711https://curecurrent.com/trials/fulvestrant-500mg-in-patients-with-advanced-breast-cancer-33712https://curecurrent.com/trials/vinorelbine-plus-apatinib-versus-vinorelbine-in-advanced-triple-negative-breast-cancer-33713https://curecurrent.com/trials/dynamic-observational-study-with-pet-of-68ga-her2-affibody-in-anti-her2-treatment-33714https://curecurrent.com/trials/phase-2-study-to-evaluate-pvx-410-pembrolizumab-chemotherapy-for-metastatic-pd-l1-triple-negative-breast-cancer-33715https://curecurrent.com/trials/trial-of-neoadjuvant-docetaxel-metronomic-capecitabine-ctx-followed-by-fec-in-women-with-operable-triple-negative-breast-33716https://curecurrent.com/trials/dp303c-in-patients-with-her2-positive-unresectable-locally-advanced-relapsed-or-metastaticbreast-cancer-33717https://curecurrent.com/trials/the-heartspare-plus-1b-trial-33718https://curecurrent.com/trials/anlotinib-combined-with-chemotherapy-for-the-treatment-of-her2-negative-advanced-breast-cancer-33719https://curecurrent.com/trials/ramosetron-on-late-ponv-postoperative-nausea-and-vomiting-33720https://curecurrent.com/trials/ct-based-radiomics-of-aln-pcr-ypn0-in-breast-cancer-undergoing-nac-33721https://curecurrent.com/trials/selective-omission-of-axillary-surgery-in-triple-negative-and-her2-positive-breast-cancer-after-nact-33722https://curecurrent.com/trials/combination-therapy-of-f16il2-and-paclitaxel-in-solid-tumour-patients-33723https://curecurrent.com/trials/a-study-of-rc48-adc-for-the-treatment-of-her2-expression-metastatic-breast-cancer-with-abnormal-activation-of-pam-pathwa-33724https://curecurrent.com/trials/effectiveness-of-mobile-messenger-initiated-reminder-on-biannual-mammography-adherence-in-breast-cancer-screening-33725https://curecurrent.com/trials/neratinib-fulvestrant-in-metastatic-her2-non-amplified-but-her2-mutant-breast-cancer-33726https://curecurrent.com/trials/phase-2-study-of-spi-2012-or-pegfilgrastim-for-the-management-of-neutropenia-in-participants-with-breast-cancer-33727https://curecurrent.com/trials/assessing-the-utility-of-tissue-dielectric-constant-tdc-measurements-to-differentiate-breast-cancer-from-healthy-breasts-33728https://curecurrent.com/trials/study-of-preoperative-boost-radiotherapy-33729https://curecurrent.com/trials/a-study-of-budigalimab-abbv-181-in-participants-with-advanced-solid-tumors-33730https://curecurrent.com/trials/ac-vs-tc-in-patients-with-hr-positive-her2-negative-early-breast-cancer-33731https://curecurrent.com/trials/radiation-therapy-wbi-versus-pbi-in-treating-women-who-have-undergone-surgery-for-ductal-carcinoma-in-situ-or-stage-i-or-33732https://curecurrent.com/trials/evaluation-of-treatment-efficacy-by-circulating-tumor-cell-phenotype-surveillance-in-breast-cancer-patients-33733https://curecurrent.com/trials/hr-positive-her2-negative-advanced-breast-cancer-with-progression-after-endocrine-therapy-33734https://curecurrent.com/trials/phase-1-study-to-evaluate-the-effect-of-ds-8201a-on-the-qt-qtc-interval-and-pharmacokinetics-in-her2-expressing-breast-c-33735https://curecurrent.com/trials/a-safety-and-preliminary-efficacy-study-of-sbt6290-alone-and-in-combination-with-pd-l-1-inhibitors-in-select-advanced-so-33736https://curecurrent.com/trials/us-guided-erector-spinae-plane-block-in-breast-cancer-surgery-analgesia-spread-and-immunomodulation-33737https://curecurrent.com/trials/improving-access-to-breast-cancer-screening-and-treatment-in-nigeria-the-triple-mobile-assessment-and-patient-navigation-33738https://curecurrent.com/trials/ucla-breast-cancer-survivor-health-promotion-research-study-33739https://curecurrent.com/trials/the-impact-of-chronic-mitochondrial-antioxidant-supplementation-on-cardiovasculartoxicity-in-breast-cancer-patients-33740https://curecurrent.com/trials/a-study-of-ly3023414-in-participants-with-advanced-cancer-33741https://curecurrent.com/trials/promoting-earlier-detection-of-breast-cancer-in-rwanda-scaleup-in-the-national-health-care-system-33742https://curecurrent.com/trials/pyrotinib-maleate-combined-with-vinorelbine-in-the-treatment-of-her2-positive-advanced-breast-cancer-33743https://curecurrent.com/trials/mastectomy-in-ambulatory-breast-surgery-33744https://curecurrent.com/trials/h-trastuzumab-or-biosimilar-combined-with-cdk4-6-inhibitor-ai-ofs-in-the-treatment-of-hr-her2-advanced-breast-cancer-eff-33745https://curecurrent.com/trials/heat-activated-target-therapy-of-local-regional-relapse-in-breast-cancer-patients-33746https://curecurrent.com/trials/neoadjuvant-therapy-study-guided-by-drug-screening-in-vitro-for-human-epidermal-growth-factor-receptor-2-her2-negative-e-33747https://curecurrent.com/trials/opt-in-vs-opt-out-for-breast-cancer-screening-33748https://curecurrent.com/trials/dexmedetomidine-in-erector-spinae-block-in-postoperative-analgesia-33749https://curecurrent.com/trials/decitabine-plus-carboplatin-in-the-treatment-of-metastatic-tnbc-33750https://curecurrent.com/trials/car-t-intraperitoneal-infusions-for-cea-expressing-adenocarcinoma-peritoneal-metastases-or-malignant-ascites-ipc-33751https://curecurrent.com/trials/genetic-predictors-of-response-to-acupuncture-for-cancer-related-fatigue-among-breast-cancer-patients-after-chemotherapy-33752https://curecurrent.com/trials/neomet-study-in-neoadjuvant-treatment-of-breast-cancer-33753https://curecurrent.com/trials/tranexamic-acid-for-alloplastic-breast-reconstruction-33754https://curecurrent.com/trials/probiotics-and-breast-health-33755https://curecurrent.com/trials/evaluation-of-a-new-technique-to-fill-the-defect-generated-after-conservative-surgery-in-breast-cancer-33756https://curecurrent.com/trials/a-trial-of-hrs-8080-tablets-in-metastatic-or-local-advanced-breast-cancer-of-adults-33757https://curecurrent.com/trials/phase-ii-study-of-everolimus-beyond-progression-33758https://curecurrent.com/trials/opioid-free-anesthesia-in-breast-cancer-surgery-33759https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-in-participants-with-human-epidermal-growth-factor-receptor-2-her2-positive-breast-canc-33760https://curecurrent.com/trials/l19tnf-in-combination-with-doxorubicin-in-patients-with-advanced-solid-tumours-33761https://curecurrent.com/trials/personalized-electroacupuncture-treatment-for-chemotherapy-induced-nausea-and-vomiting-in-breast-cancer-pet-33762https://curecurrent.com/trials/rebastinib-plus-antitubulin-therapy-with-paclitaxel-or-eribulin-in-metastatic-breast-cancer-33763https://curecurrent.com/trials/a-dose-escalation-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ipi-549-33764https://curecurrent.com/trials/vaccination-with-autologous-breast-cancer-cells-engineered-to-secrete-granulocyte-macrophage-colony-stimulating-factor-g-33765https://curecurrent.com/trials/a-phase-i-study-of-a-therapeutic-vaccine-candidate-in-patients-with-localized-breast-cancer-at-high-risk-of-relapse-33766https://curecurrent.com/trials/nurse-amie-for-echo-show-randomized-control-trial-33767https://curecurrent.com/trials/roll-over-study-to-continue-treatment-with-the-investigational-drug-rogaratinib-and-to-further-test-its-safety-33768https://curecurrent.com/trials/onapristone-as-preoperative-treatment-for-postmenopausal-women-with-hormone-receptor-and-her2-breast-cancer-33769https://curecurrent.com/trials/autologous-vaccination-with-lethally-irradiated-autologous-breast-cancer-cells-engineered-to-secrete-gm-csf-in-women-wit-33770https://curecurrent.com/trials/magnetic-tracer-in-the-sentinel-node-procedure-in-breast-cancer-the-non-radioactive-alternative-for-radio-isotopes-33771https://curecurrent.com/trials/optimizing-irradiation-through-molecular-assessment-of-lymph-node-optimal-33772https://curecurrent.com/trials/phase-i-study-of-eoc202-plus-paclitaxel-in-chinese-patients-with-metastatic-breast-cancer-33773https://curecurrent.com/trials/excel-exercise-for-cancer-to-enhance-living-well-33774https://curecurrent.com/trials/adjuvant-albumin-bound-paclitaxel-versus-taxanes-in-breast-cancer-a-real-world-study-33775https://curecurrent.com/trials/breast-mri-in-evaluation-of-pathologic-response-in-patients-with-breast-cancer-with-neoadjuvent-chemotherapy-33776https://curecurrent.com/trials/pyrotinib-trastuzumab-pertuzumab-and-nab-paclitaxel-as-neoadjuvant-therapy-in-her2-positive-breast-cancer-33777https://curecurrent.com/trials/multimodal-ultrasonographic-assessment-of-ipsilateral-axillary-lymph-nodes-in-patients-with-breast-cancer-a-stard-study-33778https://curecurrent.com/trials/real-time-tissue-characterisation-using-mass-spectrometry-rei-excise-iknife-study-33779https://curecurrent.com/trials/pembrolizumab-combined-with-itacitinib-incb039110-and-or-pembrolizumab-combined-with-incb050465-in-advanced-solid-tumors-33780https://curecurrent.com/trials/implantation-of-cest-and-cesl-mri-methods-for-detection-of-breast-tumors-33781https://curecurrent.com/trials/assessment-of-feasibility-and-acceptability-of-personalized-breast-cancer-screening-33782https://curecurrent.com/trials/t-cell-receptor-immunotherapy-targeting-mage-a3-for-patients-with-metastatic-cancer-who-are-hla-dp0401-positive-33783https://curecurrent.com/trials/the-role-of-interleukin-7-serum-level-as-biological-marker-in-breast-cancer-33784https://curecurrent.com/trials/clinical-trial-to-assess-pharmacokinetic-parameters-and-safety-of-nng-tmab-trastuzumab-on-recurrent-or-metastatic-breast-33785https://curecurrent.com/trials/trivandrum-breast-cancer-screening-trial-33786https://curecurrent.com/trials/a-study-of-pdr001-in-combination-with-cjm112-egf816-ilaris-canakinumab-or-mekinist-trametinib-33787https://curecurrent.com/trials/immunonutrition-and-carbohydrate-loading-strategies-in-breast-reconstruction-33788https://curecurrent.com/trials/effects-of-a-traditional-chinese-exercise-program-on-symptom-cluster-in-breast-cancer-patients-33789https://curecurrent.com/trials/identification-of-novel-inflammation-related-biomarkers-for-early-detection-of-anthracycline-induced-cardiotoxicity-in-b-33790https://curecurrent.com/trials/efficacy-of-high-dose-tamoxifen-to-advanced-hormone-receptor-high-expressed-breast-cancer-33791https://curecurrent.com/trials/prevalence-of-depression-and-anxiety-among-breast-cancer-patients-33792https://curecurrent.com/trials/a-study-comparing-immunopheresis-alone-or-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-treatment-of-adv-33793https://curecurrent.com/trials/study-to-evaluate-the-benefit-of-a-high-frequency-ventilation-system-during-lung-or-breast-cancer-radiotherapy-treatment-33794https://curecurrent.com/trials/irb-hsr-13957-iv-lidocaine-for-patients-undergoing-primary-breast-cancer-surgery-33795https://curecurrent.com/trials/compare-continuation-of-original-targeted-therapy-with-trastuzumab-combined-with-pyrotinib-and-capecitabine-as-postopera-33796https://curecurrent.com/trials/pbmt-for-the-management-of-cia-hairlaser-33797https://curecurrent.com/trials/trilaciclib-g1t28-a-cdk-4-6-inhibitor-in-combination-with-gemcitabine-and-carboplatin-in-metastatic-triple-negative-brea-33798https://curecurrent.com/trials/inetetamab-combined-with-anti-pd-1-monoclonal-antibody-and-albumin-bound-paclitaxel-for-her2-metastatic-breast-cancer-33799https://curecurrent.com/trials/nivolumab-after-induction-treatment-in-triple-negative-breast-cancer-tnbc-patients-33800https://curecurrent.com/trials/immune-induction-strategies-to-improve-response-to-immune-checkpoint-blockade-in-triple-negative-breast-cancer-tnbc-pati-33801https://curecurrent.com/trials/physical-activity-intervention-to-reduce-functional-health-disparities-among-breast-cancer-survivors-33802https://curecurrent.com/trials/er-her2-locally-advanced-or-metastatic-breast-cancer-enzeno-study-33803https://curecurrent.com/trials/descriptive-observational-study-of-the-evolution-of-the-lifestyle-alteration-in-patients-with-breast-cancer-33804https://curecurrent.com/trials/a-study-to-determine-safety-and-tolerability-of-gmi-1359-in-subjects-with-hr-metastatic-breast-cancer-33805https://curecurrent.com/trials/efficacy-of-talazoparib-in-asian-metastatic-breast-cancer-patients-with-a-homologous-recombinant-deficiency-hrd-signatur-33806https://curecurrent.com/trials/qol-of-women-with-hr-positive-metastatic-bc-treated-in-the-first-line-setting-comparison-between-public-and-private-inst-33807https://curecurrent.com/trials/effectiveness-of-pnf-training-for-improving-for-muscle-strength-function-and-pain-after-axillary-lymph-node-dissection-33808https://curecurrent.com/trials/effectiveness-of-fluoroscopy-guided-mld-for-treatment-of-bcrl-33809https://curecurrent.com/trials/gut-microbiome-gastrointestinal-toxicities-as-determinants-of-response-to-neoadjuvant-chemo-for-advanced-breast-cancer-33810https://curecurrent.com/trials/a-study-of-palbociclib-in-combination-with-fulvestrant-or-tamoxifen-as-treatment-for-metastatic-breast-cancer-33811https://curecurrent.com/trials/effect-of-the-app-bone-bc-version-4-0-under-the-follow-up-for-patients-with-early-breast-cancer-33812https://curecurrent.com/trials/efficacy-of-letrozole-palbociclib-combination-as-neoadjuvant-treatment-of-stage-ii-iiia-pam-50-ror-defined-low-or-interm-33813https://curecurrent.com/trials/pembrolizumab-in-combination-with-paclitaxel-in-the-hormone-receptor-positive-metastatic-breast-cancer-with-high-tumor-m-33814https://curecurrent.com/trials/nurse-navigation-program-based-on-health-belief-model-in-breast-cancer-screening-naheb-cas-33815https://curecurrent.com/trials/skin-protection-during-radiotherapy-in-patients-with-breast-cancer-33816https://curecurrent.com/trials/prediction-of-upgrade-to-invasive-cancer-in-patients-diagnosed-with-ductal-carcinoma-in-situ-by-percutaneous-core-needle-33817https://curecurrent.com/trials/outcome-of-tucidinostat-based-therapy-in-hr-metastatic-breast-cancer-patients-previously-treated-with-cdk4-6-inhibitor-33818https://curecurrent.com/trials/study-of-poziotinib-in-participants-with-her2-positive-metastatic-breast-cancer-33819https://curecurrent.com/trials/hypo-versus-conventional-fractionation-in-reconstructed-breast-cancer-mastectomy-patients-33820https://curecurrent.com/trials/a-pharmacokinetic-comparison-study-of-syhx2011-and-abraxane-in-patients-with-advanced-breast-cancer-33821https://curecurrent.com/trials/efficacy-of-preoperative-radiotherapy-for-non-responder-patients-after-neoadjuvant-chemotherapy-33822https://curecurrent.com/trials/the-quilt-study-quilting-sutures-in-patients-undergoing-breast-cancer-surgery-33823https://curecurrent.com/trials/onc201-with-a-methionine-restricted-diet-in-patients-with-metastatic-triple-negative-breast-cancer-33824https://curecurrent.com/trials/bioequivalence-study-of-doxorubicin-hydrochloride-liposome-injection-lipodox-in-chinese-patients-33825https://curecurrent.com/trials/safety-and-immunogenicity-of-a-personalized-synthetic-long-peptide-breast-cancer-vaccine-strategy-in-patients-with-persi-33826https://curecurrent.com/trials/cardiac-rehabilitation-program-in-improving-cardiorespiratory-fitness-in-stage-0-iii-breast-cancer-survivors-33827https://curecurrent.com/trials/mindfulness-and-self-compassion-focussed-walking-33828https://curecurrent.com/trials/pilot-study-of-the-effect-of-duavee-on-benign-breast-tissue-proliferation-33829https://curecurrent.com/trials/increasing-knowledge-of-alcohol-as-a-risk-factor-for-breast-cancer-among-women-attending-breast-screening-services-33830https://curecurrent.com/trials/acceptability-of-3d-printed-breast-models-as-surgical-decision-aids-for-breast-cancer-treatment-33831https://curecurrent.com/trials/parp-inhibitor-on-advanced-metastatic-breast-cancer-in-germline-palb2-mutations-carriers-33832https://curecurrent.com/trials/dosimetric-comparison-of-doses-in-both-positions-prone-and-decubitus-for-patient-with-breast-cancer-33833https://curecurrent.com/trials/whole-brain-radiotherapy-wbrt-with-sorafenib-for-breast-cancer-brain-metastases-bcbm-33834https://curecurrent.com/trials/clinical-implementation-of-a-polygenic-risk-score-prs-for-breast-cancer-33835https://curecurrent.com/trials/radiation-therapy-and-m7824-in-treating-patients-with-metastatic-hormone-receptor-positive-her2-negative-breast-cancer-33836https://curecurrent.com/trials/a-prospective-post-marketing-observational-safety-study-of-verzenios-abemaciclib-among-breast-cancer-patients-in-china-v-33837https://curecurrent.com/trials/assessment-of-cognitive-function-after-surgery-in-two-types-of-anesthesia-in-patients-operated-for-breast-cancer-33838https://curecurrent.com/trials/bruog-291-five-fraction-partial-breast-irradiation-using-non-invasive-image-guided-breast-brachytherapy-nibb-33839https://curecurrent.com/trials/biomarkers-and-cardiac-mri-as-early-indicators-of-cardiac-exposure-following-breast-radiotherapy-33840https://curecurrent.com/trials/gemcitabine-combined-with-eribulin-regimen-in-the-treatment-of-second-line-above-recurrent-her2-negative-breast-cancer-33841https://curecurrent.com/trials/preoperative-hormone-therapy-for-postmenopausal-women-with-er-clinical-stage-t2-4-tumors-33842https://curecurrent.com/trials/coping-after-breast-cancer-a-randomized-clinical-trial-with-two-digital-interventions-33843https://curecurrent.com/trials/evaluation-of-neratinib-for-treatment-and-prevention-of-subsequent-cns-event-s-in-patients-with-brain-metastasis-of-adva-33844https://curecurrent.com/trials/spi-2012-vs-pegfilgrastim-in-management-of-neutropenia-in-breast-cancer-participants-with-docetaxel-and-cyclophosphamide-33845https://curecurrent.com/trials/prevention-of-lymphedema-among-breast-cancer-patients-through-implementation-of-an-integrative-therapy-program-itp-33846https://curecurrent.com/trials/physical-exercise-for-breast-cancer-survivors-face-to-face-versus-home-based-33847https://curecurrent.com/trials/impact-of-adjuvant-hormone-therapy-on-bone-and-cardiovascular-risk-33848https://curecurrent.com/trials/a-study-of-diarrhea-and-intestinal-flora-changes-caused-by-pyrotinib-in-breast-cancer-33849https://curecurrent.com/trials/spi-2012-vs-pegfilgrastim-in-the-management-of-neutropenia-in-participants-with-breast-cancer-with-docetaxel-and-cycloph-33850https://curecurrent.com/trials/sodium-23na-mri-for-tumour-characterisation-and-assessment-of-therapy-response-in-breast-cancer-33851https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-cesm-study-33852https://curecurrent.com/trials/online-group-therapy-for-breast-cancer-33853https://curecurrent.com/trials/high-intensity-interval-training-for-women-at-heightened-risk-for-breast-cancer-33854https://curecurrent.com/trials/an-innovative-smartphone-application-for-adverse-event-management-during-breast-cancer-adjuvant-chemotherapy-33855https://curecurrent.com/trials/dasatinib-in-combination-with-zoledronic-acid-for-the-treatment-of-breast-cancer-with-bone-metastasis-33856https://curecurrent.com/trials/safety-and-efficacy-of-toripalimab-in-her2-metastatic-breast-cancer-patients-treated-with-metronomic-vinorelbine-33857https://curecurrent.com/trials/ct-angiography-prior-to-diep-flap-breast-reconstruction-33858https://curecurrent.com/trials/a-trial-using-ctdna-blood-tests-to-detect-cancer-cells-after-standard-treatment-to-trigger-additional-treatment-in-early-33859https://curecurrent.com/trials/pyrotinib-plus-trastuzumab-after-first-line-th-p-treatment-with-her-2-positive-breast-cancer-33860https://curecurrent.com/trials/phase-i-ii-study-to-evaluate-the-safety-and-tolerability-of-liplacis-in-patients-with-advanced-or-refractory-tumours-33861https://curecurrent.com/trials/chidamide-combined-with-exemestane-goserelin-versus-neoadjuvant-chemotherapy-in-patients-of-stage-ii-iii-hr-positive-her-33862https://curecurrent.com/trials/nab-paclitaxel-compared-with-docetaxel-in-the-neoadjuvant-chemotherapy-breast-cancer-33863https://curecurrent.com/trials/t-dm1-and-non-pegylated-liposomal-doxorubicin-in-human-epidermal-growth-factor-receptor-2-her2-positive-metastatic-breas-33864https://curecurrent.com/trials/dose-escalation-induction-of-everolimus-33865https://curecurrent.com/trials/efficacy-of-olanzapine-netupitant-and-palonosetron-in-controlling-nausea-and-vomiting-associated-with-highly-emetogenic-33866https://curecurrent.com/trials/a-community-dance-intervention-engaging-breast-cancer-survivors-in-a-middle-income-country-33867https://curecurrent.com/trials/vaginal-prasterone-in-vaginal-atrophy-in-breast-cancer-survivors-33868https://curecurrent.com/trials/clinical-evaluation-of-cem-guided-biopsy-33869https://curecurrent.com/trials/geriatric-determinants-of-curative-radiotherapy-scheme-choice-for-breast-cancer-elderly-patient-treatment-compliance-and-33870https://curecurrent.com/trials/tumor-infiltrating-lymphocytes-and-programmed-cell-death-ligand-1-in-breast-cancer-33871https://curecurrent.com/trials/rav12-in-treating-patients-with-metastatic-or-recurrent-adenocarcinoma-33872https://curecurrent.com/trials/evaluating-a-digital-tool-for-supporting-breast-cancer-patients-33873https://curecurrent.com/trials/breast-reconstruction-with-external-pre-expansion-and-autologous-fat-transfer-versus-standard-therapy-33874https://curecurrent.com/trials/digital-breast-tomosynthesis-dbt-to-improve-assessment-of-resection-margins-in-invasive-breast-cancer-33875https://curecurrent.com/trials/study-of-cb-839-telaglenastat-in-combination-with-talazoparib-in-patients-with-solid-tumors-33876https://curecurrent.com/trials/effects-of-a-physical-exercise-program-in-quality-of-life-of-breast-cancer-survivors-33877https://curecurrent.com/trials/effects-of-us-guided-sapb-during-breast-surgery-33878https://curecurrent.com/trials/effects-of-cancer-symptoms-on-caregivers-33879https://curecurrent.com/trials/artificial-intelligence-analysis-for-magnetic-resonance-imaging-in-screening-and-diagnosis-of-breast-cancer-33880https://curecurrent.com/trials/axillary-lymph-node-treatment-guided-by-naocarbon-tracing-after-neoadjuvant-chemotherapy-33881https://curecurrent.com/trials/efficacy-and-safety-study-with-myl-1401h-and-neulasta-33882https://curecurrent.com/trials/prevention-of-taxane-associated-acute-pain-syndrome-with-etoricoxib-33883https://curecurrent.com/trials/a-phase-2-study-of-ezn-2208-in-patients-with-metastatic-breast-cancer-33884https://curecurrent.com/trials/study-to-explore-the-safety-tolerability-and-efficacy-of-mk-3475-in-combination-with-incb024360-in-participants-with-sel-33885https://curecurrent.com/trials/study-of-efficacy-and-safety-of-myl1401o-taxane-vs-herceptin-taxane-for-1st-line-met-br-ca-33886https://curecurrent.com/trials/the-significance-of-radiologically-detected-intramammary-lymph-nodes-in-prediction-of-axillary-lymph-nodes-status-in-bre-33887https://curecurrent.com/trials/letrozole-and-lapatinib-followed-by-everolimus-in-women-with-advanced-breast-cancer-33888https://curecurrent.com/trials/safety-and-efficacy-of-lag525-single-agent-and-in-combination-with-pdr001-in-patients-with-advanced-malignancies-33889https://curecurrent.com/trials/dragonboat-activity-for-breast-cancer-33890https://curecurrent.com/trials/risas-procedure-in-node-positive-breast-cancer-following-nac-33891https://curecurrent.com/trials/estradiol-levels-in-patients-treated-with-estring-33892https://curecurrent.com/trials/the-use-of-fes-pet-imaging-as-a-tool-to-detect-a-possible-reversion-of-estrogen-receptor-er-status-in-patients-with-meta-33893https://curecurrent.com/trials/effects-of-ketogenic-diet-in-overweight-and-obese-women-with-breast-cancer-33894https://curecurrent.com/trials/the-immersive-experience-of-virtual-reality-during-chemotherapy-in-patients-with-early-breast-and-gynecological-cancers-33895https://curecurrent.com/trials/phase-i-study-of-combination-of-gedatolisib-with-palbociclib-and-faslodex-in-patients-with-er-her2-breast-cancer-33896https://curecurrent.com/trials/tyrosine-kinase-inhibitors-tkis-in-trastuzumab-emtansine-t-dm1-resistant-her2-positive-metastatic-breast-cancer-a-real-w-33897https://curecurrent.com/trials/aesthetic-outcomes-of-oncoplastic-breast-surgery-for-breast-cancer-in-the-upper-inner-quadrant-33898https://curecurrent.com/trials/type-i-interferon-alfa-2a-in-postmastectomy-breast-reconstruction-33899https://curecurrent.com/trials/tacrolimus-as-treatment-of-breast-cancer-related-lymphedema-33900https://curecurrent.com/trials/phase-1b-study-of-pd-0332991-in-combination-with-t-dm1-trastuzumab-dm1-33901https://curecurrent.com/trials/safety-study-of-mga271-in-refractory-cancer-33902https://curecurrent.com/trials/p2-clinical-efficacy-safety-study-of-v-111-monotherapy-sacituzumab-govitecan-hziy-v-111-combo-therapy-for-mtnbc-33903https://curecurrent.com/trials/breast-stereotactic-radiotherapy-to-primary-tumors-in-metastatic-patients-33904https://curecurrent.com/trials/safety-study-of-mgd009-in-b7-h3-expressing-tumors-33905https://curecurrent.com/trials/dfs-and-qol-after-modified-radical-mastectomy-vs-expanded-mckissock-surgery-for-eic-of-the-breast-33906https://curecurrent.com/trials/star-cape-bkm120-mbc-with-brain-met-33907https://curecurrent.com/trials/alexandria-study-egypt-33908https://curecurrent.com/trials/study-to-determine-safety-and-dose-of-njh395-in-non-breast-her2-advanced-cancer-33909https://curecurrent.com/trials/livial-intervention-following-breast-cancer-efficacy-recurrence-and-tolerability-endpoints-liberate-completed-p05885-33910https://curecurrent.com/trials/analysis-of-tumors-from-patients-with-inherited-cancers-having-had-two-surgeries-primary-recurrent-or-2-separate-types-o-33911https://curecurrent.com/trials/low-dose-apatinib-combined-with-neoadjuvant-chemotherapy-in-the-treatment-of-early-triple-negative-breast-cancer-33912https://curecurrent.com/trials/177lu-j591-antibody-in-patients-with-nonprostate-metastatic-solid-tumors-33913https://curecurrent.com/trials/a-study-of-metronomic-cp-and-jx-594-in-patients-with-advanced-breast-cancer-and-advanced-soft-tissue-sarcoma-metromajx-33914https://curecurrent.com/trials/cardiotoxicity-prevention-in-breast-cancer-patients-treated-with-anthracyclines-and-or-trastuzumab-33915https://curecurrent.com/trials/neoadj-ph-2-ai-plus-everolimus-in-postmenopausal-women-w-er-pos-her2-neg-low-risk-score-33916https://curecurrent.com/trials/safety-and-efficacy-of-recombinant-oncolytic-adenovirus-l-ifn-injection-in-relapsed-refractory-solid-tumors-clinical-stu-33917https://curecurrent.com/trials/can-chronic-post-surgical-pain-be-reduced-by-preserving-intercostobrachial-nerve-during-axillary-lymph-node-dissection-a-33918https://curecurrent.com/trials/phase-i-ib-study-of-nis793-in-combination-with-pdr001-in-patients-with-advanced-malignancies-33919https://curecurrent.com/trials/minocycline-hydrochloride-in-reducing-chemotherapy-induced-peripheral-neuropathy-and-acute-pain-in-patients-with-breast-33920https://curecurrent.com/trials/local-and-regional-radiotherapy-for-nipple-sparing-mastectomy-with-implant-33921https://curecurrent.com/trials/innovative-scoring-system-in-breast-cancer-post-neoadiuvant-chemotherapy-33922https://curecurrent.com/trials/ultrasound-assisted-cnss-mapping-versus-dual-tracer-guided-sentinel-lymph-node-biopsy-33923https://curecurrent.com/trials/bubble-a-new-vr-ai-way-of-treatment-for-hot-flashes-in-women-with-breast-cancer-33924https://curecurrent.com/trials/adapted-fencing-in-breast-cancer-a-pilot-study-33925https://curecurrent.com/trials/using-deep-learning-methods-to-analyze-automated-breast-ultrasound-and-hand-held-ultrasound-images-to-establish-a-diagno-33926https://curecurrent.com/trials/cancer-predictive-score-on-breast-mri-33927https://curecurrent.com/trials/breast-cancer-rehabilitation-with-acupuncture-and-physical-therapy-protocol-33928https://curecurrent.com/trials/surgical-site-infection-with-0-05-chlorhexidine-chg-compared-to-triple-antibiotic-irrigation-33929https://curecurrent.com/trials/effect-of-parp-inhibitors-on-glomerular-filtration-rate-33930https://curecurrent.com/trials/health-care-disparities-in-culturally-diverse-special-needs-disadvantaged-populations-bridging-the-gap-33931https://curecurrent.com/trials/continuation-study-of-entinostat-in-combination-with-pembrolizumab-in-patients-with-advanced-solid-tumors-33932https://curecurrent.com/trials/the-diagnosis-and-prognosis-of-nonpalpable-breast-cancer-detected-by-the-us-vs-mammography-a-clinical-noninferiority-tri-33933https://curecurrent.com/trials/feasibility-of-high-levels-of-energy-expenditure-from-physical-activity-for-breast-cancer-survivors-33934https://curecurrent.com/trials/docosahexaenoic-acid-dha-to-prevent-development-of-cognitive-dysfunction-due-to-chemotherapy-33935https://curecurrent.com/trials/weight-loss-plus-omega-3-fatty-acids-or-placebo-in-high-risk-women-33936https://curecurrent.com/trials/teel-study-phase-1-tamoxifen-and-ribociclib-lee011-in-advanced-er-her2-negative-breast-cancer-33937https://curecurrent.com/trials/radiation-dose-intensity-study-in-breast-cancer-in-young-women-33938https://curecurrent.com/trials/nurse-amie-addressing-metastatic-individuals-everyday-33939https://curecurrent.com/trials/espb-and-rib-for-pain-management-following-mastectomy-surgery-33940https://curecurrent.com/trials/prospective-registry-trial-for-single-port-robot-assisted-nipple-sparing-mastectomy-sprnsm-33941https://curecurrent.com/trials/a-study-evaluating-talazoparib-bmn-673-a-parp-inhibitor-in-advanced-and-or-metastatic-breast-cancer-patients-with-brca-m-33942https://curecurrent.com/trials/palbociclib-plus-letrozole-for-postmenopausal-women-with-hr-her2-advanced-breast-cancer-for-whom-letrozole-is-deemed-app-33943https://curecurrent.com/trials/ctc-changes-and-efficacy-of-neoadjuvant-chemotherapy-for-triple-negative-breast-cancer-33944https://curecurrent.com/trials/poziotinib-in-patients-with-her2-recurrent-stage-iv-bc-who-have-received-at-least-2-prior-her2-directed-regimens-33945https://curecurrent.com/trials/hair-safe-study-scalp-cooling-for-hair-saving-in-women-undergoing-chemotherapy-33946https://curecurrent.com/trials/deep-inspiration-breath-hold-radiotherapy-for-left-sided-breast-cancer-33947https://curecurrent.com/trials/music-listening-in-radiotherapy-treatment-33948https://curecurrent.com/trials/brca1-2-and-effect-of-mifepristone-on-the-breast-33949https://curecurrent.com/trials/bevacizumab-metronomic-chemotherapy-cm-diet-and-exercise-after-preoperative-chemotherapy-for-breast-cancer-33950https://curecurrent.com/trials/improving-cancer-outcomes-through-personalized-care-planning-and-symptom-management-33951https://curecurrent.com/trials/clinical-study-of-alt-p7-to-determine-safety-tolerability-and-pharmacokinetics-in-breast-cancer-patients-33952https://curecurrent.com/trials/clinical-study-of-fulvestrant-combined-with-chidamide-in-the-treatment-of-hormone-receptor-positive-advanced-breast-canc-33953https://curecurrent.com/trials/trial-to-compare-the-safety-efficacy-and-immunogenicity-of-tx05-with-herceptin-in-her2-early-breast-cancer-33954https://curecurrent.com/trials/the-gamma-pod-a-clinical-feasibility-study-device-gcc-1202-the-gamma-pod-a-clinical-feasibility-study-33955https://curecurrent.com/trials/comparison-of-different-volumes-spread-of-erector-spinae-block-in-post-mastectomy-pain-syndrome-management-33956https://curecurrent.com/trials/genotyping-2-snps-in-chinese-breast-cancers-33957https://curecurrent.com/trials/a-phase-ii-randomized-study-evaluating-the-biological-and-clinical-effects-of-the-combination-of-palbociclib-with-letroz-33958https://curecurrent.com/trials/supervised-resistance-training-among-women-at-risk-of-breast-cancer-related-lymphedema-33959https://curecurrent.com/trials/analgesic-effect-of-resistance-training-for-breast-cancer-survivors-33960https://curecurrent.com/trials/efficacy-and-safety-of-adjuvant-docetaxel-and-trastuzumab-in-stage-i-her2-positive-breast-cancer-33961https://curecurrent.com/trials/trastuzumab-henlius-combined-with-pertuzumab-perjeta-and-chemotherapy-in-chinese-patients-with-her2-positive-metastatic-33962https://curecurrent.com/trials/trial-of-chidamide-in-combination-with-exemestane-in-patients-with-advanced-breast-cancer-33963https://curecurrent.com/trials/comparative-analysis-of-three-locoregional-anesthesia-methods-in-breast-tumour-pathology-surgery-33964https://curecurrent.com/trials/a-trial-of-camrelizumab-in-combination-with-nab-paclitaxel-and-famitinib-as-a-first-line-treatment-in-patients-with-unre-33965https://curecurrent.com/trials/bn-brachyury-entinostat-adotrastuzumab-emtansine-and-m7824-in-advanced-stage-breast-cancer-breast-33966https://curecurrent.com/trials/radiotherapy-for-extracranial-oligometastatic-breast-cancer-33967https://curecurrent.com/trials/anrotinib-in-combination-with-capecitabine-in-advanced-triple-negative-breast-cancer-33968https://curecurrent.com/trials/improvement-of-range-of-motion-in-frozen-shoulder-in-breast-cancer-survivors-33969https://curecurrent.com/trials/comparison-of-three-methods-for-early-detection-of-breast-cancer-33970https://curecurrent.com/trials/impact-of-ehealth-support-on-quality-of-life-in-metastatic-breast-cancer-patients-treated-with-palbociclib-and-endocrine-33971https://curecurrent.com/trials/physical-activity-to-maintain-quality-of-life-and-physical-function-in-women-with-metastatic-breast-cancer-a-pilot-study-33972https://curecurrent.com/trials/biomarkers-of-liposomal-doxorubicin-induced-hypersensitivity-reaction-in-breast-cancer-patients-33973https://curecurrent.com/trials/impact-of-oncotype-dx-on-treatment-recommendation-and-its-economic-evaluation-under-the-brazilian-society-perspective-33974https://curecurrent.com/trials/dlsct-for-breast-cancer-detection-in-women-with-dense-breasts-33975https://curecurrent.com/trials/t1-t2-breast-cancer-comparison-between-removal-and-preservation-of-axillary-lymph-nodes-sinodar-one-33976https://curecurrent.com/trials/validation-of-prone-crawl-radiotherapy-for-whole-breast-irradiation-after-breast-conserving-surgery-33977https://curecurrent.com/trials/exploratory-study-of-neoadjuvant-treatment-of-her2-positive-breast-cancer-with-py-in-combination-with-hp-33978https://curecurrent.com/trials/preventing-anthracycline-cardiovascular-toxicity-with-statins-prevent-33979https://curecurrent.com/trials/durvalumab-medi4736-and-tremelimumab-in-hormone-receptor-positive-hypermutated-metastatic-breast-cancer-identified-by-wh-33980https://curecurrent.com/trials/cognitive-changes-associated-with-breast-cancer-treatment-33981https://curecurrent.com/trials/shear-wave-elastography-assessment-of-neoadjuvant-chemotherapy-response-in-patients-with-invasive-breast-cancer-33982https://curecurrent.com/trials/utidelone-plus-capecitabine-versus-taxane-plus-capecitabine-in-her2-negative-locally-advanced-or-metastatic-breast-cance-33983https://curecurrent.com/trials/study-of-docosahexaenoic-acid-dha-in-triple-negative-breast-cancer-survivors-33984https://curecurrent.com/trials/germline-brca1-and-brca2-mutations-in-jewish-women-affected-by-breast-cancer-33985https://curecurrent.com/trials/multi-parametric-breast-ultrasound-imaging-as-a-potential-biomarker-for-breast-cancer-33986https://curecurrent.com/trials/a-phase-ii-study-of-nivolumab-in-combination-with-cabozantinib-for-metastatic-triple-negative-breast-cancer-33987https://curecurrent.com/trials/study-of-the-change-of-breast-cancer-patients-upper-limb-lymphatic-drainage-pathway-after-operation-33988https://curecurrent.com/trials/prospective-cohort-study-of-breast-cancer-patients-treated-with-radiotherapy-33989https://curecurrent.com/trials/an-intervention-programme-to-reduce-cognitive-impairment-due-to-cancer-33990https://curecurrent.com/trials/a-randomized-cluster-trial-to-evaluate-a-mobile-mammography-unit-in-breast-cancer-screening-in-france-mammobile-33991https://curecurrent.com/trials/description-of-treatment-patterns-and-description-and-comparison-of-healthcare-resource-utilization-and-costs-of-women-w-33992https://curecurrent.com/trials/delayed-versus-immediate-use-of-zoledronic-acid-for-postmenopausal-patients-with-early-breast-cancer-who-are-using-adjuv-33993https://curecurrent.com/trials/economic-and-social-disparities-and-breast-cancer-33994https://curecurrent.com/trials/light-ct-in-the-diagnosis-of-breast-tumor-and-lymph-node-33995https://curecurrent.com/trials/study-to-assess-dher2-as15-cancer-vaccine-given-in-combination-with-lapatinib-to-patients-with-metastatic-breast-cancer-33996https://curecurrent.com/trials/avelumab-in-metastatic-or-locally-advanced-solid-tumors-javelin-solid-tumor-33997https://curecurrent.com/trials/pu-h71-with-nab-paclitaxel-abraxane-in-metastatic-breast-cancer-33998https://curecurrent.com/trials/capecitabine-in-metastatic-breast-and-gi-cancers-33999https://curecurrent.com/trials/single-fraction-elderly-breast-irradiation-sifebi-34000